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The prevalence of hypertension in African Americans is the highest of any population in 
the United States, and this population also demonstrates lower rates of adherence to 
mediation. Social support and patient–provider communication have been considered as 
reinforcing factors to help hypertensive patients achieve optimal blood pressure control. 
The purpose of this study was to examine the association of social support and patient–
provider communication and medication adherence for hypertensive African American 
men and women. The study was guided by the theory of reasoned action. This study was 
conducted to determine whether social support and patient–provider communication was 
associated with medication adherence by self-report, age, and gender. A quantitative 
cross-sectional design with secondary data analyses was used. The sample included 566 
hypertensive African American men and women between the ages of 21and 65 years who 
participated in a survey administered in the Counseling African Americans to Control 
Hypertension clinical trial collected between 2004 and 2011. The independent variables 
were social support and patient–provider communication; the dependent variable was 
medication adherence. Descriptive, 2-way analysis of variance and hierarchal logistic 
regression model analyses indicated a significant association between patient–provider 
communication and medication adherence. There was no significant difference in the 
relationship between social support, patient–provider communication, and age and gender 
and medication adherence. The implications of this study for social change include 
improvement in policies and development programs to support the critical role of 
providers in ensuring medication adherence in hypertensive African American patients.   
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Section 1: Foundation of the Study and Literature Review 
Introduction 
Hypertension, also known as high blood pressure, is a chronic disease that affects 
people of all ages, races, gender, and ethnic backgrounds. Uncontrolled hypertension 
remains an important health issue for patients throughout the United States (Bokhour et 
al., 2016). According to the American Heart Association (AHA; 2016), 80 million adults 
have been diagnosed with hypertension. Hypertension can also lead to the development 
of other health complications including cardiovascular disease, stroke, and kidney disease 
(Fongwa et al., 2015; Kretchy, Owusu-Daaku, & Danquah, 2013). In 2010, the mortality 
rate indicated that 360,000 American deaths had high blood pressure as a contributing 
factor (Brown, 2015). Age, family history, being overweight, a sedentary lifestyle, diet, 
and race are factors that increase the risk of an individual developing hypertension 
(Centers for Disease Control & Prevention [CDC], 2016). 
African American men and women are disproportionality affected by 
hypertension. Researchers have shown that the prevalence of hypertension in African 
Americans is 42%, which is the highest of any population in the United States (CDC, 
2016; Lewis, Ogedegbe, & Ogedegbe, 2012). In addition, African Americans have a 
lower rate of adherence to antihypertension mediation (Rimando, 2015). Medication 
adherence is defined as “the extent to which patient’s behavior coincides with medical or 
health advice, and has been associated with improved health outcomes” (Schmitt, Linder, 
& de Santa Helena, 2013, p 615). Nonadherence to medication has also been identified as 
a major public health concern, particularly for patients with hypertension. Evidence has 
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shown that nonadherence is associated with adverse health outcomes as well as higher 
healthcare costs (Nair et al., 2011). 
Improving adherence to medication in hypertensive African Americans requires 
an understanding of what influences their decision and why nonadherence occurs. Such 
barriers that affect adherence rates include cost of medication, socioeconomic status, or a 
lack of both social support and patient-provider communication (Rimando, 2015). 
Medication adherence is a multidimensional process that can also be influenced by 
patients’ health beliefs, knowledge, and attitude (Schoenthaler et al., 2016). For some 
African Americans, their intentions on adhering to treatment depend upon what people 
think or believe as well as what attitudes they hold and how other people influence them 
(Ashaye & Giles, 2003; Rimando, 2015). 
Interventions targeted at improving uncontrolled blood pressure in African 
American men and women are essential to decreasing morbidity and mortality rates. 
Social support and patient-provider communication have been considered as reinforcing 
factors to help hypertensive patients achieve optimal blood pressure control (Abel & 
Efird, 2013). However, there is a gap of knowledge in understanding how social support 
and patient-provider communication are associated with medication adherence among 
hypertensive African Americans (Lewis et al., 2012). Through this study, I aimed to 
show that improvement in patient-provider communication and social support can help 
create social change in African Americans’ attitudes towards self-management of their 




In the first section of this research study, I will discuss how hypertension among 
African Americans is a concern and explain why this study was necessary. I will also 
focus on addressing the research questions and the theoretical framework used to support 
the study. In Section 1, I will describe the literature search strategy and review the studies 
related to medication adherence, social support, and patient-provider communication 
based on an in-depth literature review. Lastly, I will define key terms and provide a brief 
description of the assumptions and delimitations that could affect the research. 
Problem Statement 
It is estimated that 30%–50% of hypertensive patients withdraw from their 
prescribed medication within 1 year, and 33% of hypertensive patients do not adhere to 
the prescribed pharmacologic dosage (Bosworth et al., 2011; Branham, Moose, & Ferreri, 
2010). A lack of effective health provider response to uncontrolled blood pressure and 
insufficient patient adherence to treatment recommendations create a problem for 
hypertensive individuals to maintain their blood pressure. Within the United States, the 
prevalence of hypertension is 46% among African American women and 43% among 
African American men (Cuffee et al., 2013; Pettey et al., 2016). African American 
women with high blood pressure tend to be more aware of their condition and likely to 
seek treatment (Flack et al., 2010). They also have relatively higher control rates than 
their male counterparts (Ashaye & Giles, 2003). 
Nevertheless, enhancing medication adherence in hypertensive African 
Americans can be challenging because poor adherence is a multifactorial problem. For 
some African Americans, low socioeconomic conditions, including poverty, high stress 
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levels, sedentary lifestyles, poor food choices, and lack of physical activity, play a role in 
blood pressure control and medication adherence (Forsyth, Schoenthaler, Ogedegbe, & 
Ravenell, 2014; Pettey et al., 2016). Both African American men and women are less 
likely compared to European Americans to adhere to high blood pressure treatment due 
to a lack of health insurance, cost of medication, no access to healthcare, or missed 
diagnosis (Lewis, 2012). Additional factors for nonadherence include low education as 
well as low health literacy; therefore, many patients lack the knowledge about the 
potential health risks and consequences of not taking their medication (Pettey et al., 
2016). Forgetting has also been found to be the most common reason for diagnosed 
patients not taking medication (Hill, Miller, & DeGeest, 2011). 
Adherence to medical treatment refers to how well and consistently a patient 
follows the management plan developed by their healthcare provider (Fongwa et al., 
2008). The consequences of nonadherence to medication can result in poor health 
outcomes and increased medical care cost (Fongwa et al., 2008). Education in managing 
high blood pressure and medication adherence are needed to improve control rates 
(Brunton, 2011; Zullig, Peterson, & Bosworth, 2013).  
There is a lack of agreement in literature as to the role social support and patient-
provider communication has on African Americans with hypertension (Cornwell & 
Waite, 2012; Lewis et al., 2012). Social support is defined as a perceived or actual 
instrumental and expressive provision supplied by the community, social networks, and 
confiding partners (Holt et al., 2014; Zimet, Dahlem, Zimet, & Farley, 1988). Social 
support has been shown to be associated with various health behaviors but has not yet 
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been clearly proven to be associated with medication adherence in African Americans 
who are diagnosed with hypertension (Lewis et al., 2012; Vaccaro, Exebio, Zarini, & 
Huffman, 2014). Likewise, empirical researchers have demonstrated that effective 
patient-provider communication can also improve health behaviors through collaboration 
between the patient and health provider (Brewer et al., 2013; Schoenthaler, Allegrante, 
Chaplin, & Ogedegbe, 2012). There is a lack of understanding, however, regarding the 
relationship between patient-provider communication and the attitudes of adherence 
towards high blood pressure treatment among African Americans (Lewis et al., 2012). 
Therefore, further research was necessary to better understand how social support and 
patient-provider communication influence the attitudes of both hypertensive African 
American men and women towards medication adherence based on age and gender. 
Purpose of Study 
The purpose of this quantitative study was to examine the association of social 
support and patient-provider communication towards medication adherence for both 
hypertensive African American men and women between the ages of 21 and 65 years old 
in the United States. Older individuals have been found to be more likely to adhere to 
medication in comparison to younger people. Grant et al. (2015) conducted a study on the 
effects of expectation of care, perceived social support, and hypertension knowledge, 
finding age to be a significant factor in medication adherence among older African 
Americans.  
The first independent variable in this study was social support, which I defined as 
support perceived or received from family, friends, health providers, faith and community 
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organizations, and social networking groups or programs that specifically help 
hypertensive individuals. The construct of social support can be measured in two 
different ways—perceived or received support—utilizing dimensions such as emotional, 
instrumental, and informational support (Gallant, 2003). Emotional support is associated 
with sharing life experiences, while informational support focuses on the provision of 
advice, suggestions, and information that a person can use to address problems (Strom & 
Egede, 2012). Instrumental support involves tangible help or services that directly assist a 
person in need and is provided by close friends, neighbors, or colleagues (University of 
Twente, 2010). The second independent variable was patient-provider communication, 
which was defined as patients’ perception of their provider and the clarity of advice given 
to them. Patient-provider communication can be measured by assessing patients’ 
experience of care or the degree to which their doctor provides information (Levinson, 
Lesser, & Epstein, 2010). 
The dependent variable was adherence to high blood pressure medication, which I 
defined as how well and consistently a patient follows recommended treatment and the 
plan developed by his or her healthcare provider. The control variables were gender, age, 
income, education, employment, insurance status, and place of residence. The length of 
time in treatment, number of medications, and the severity of hypertension were also 
used as control variables. These demographic variables were used as baseline 




Research Questions and Hypotheses  
In this research study, I aimed to answer the following research questions by 
evaluating their associated hypotheses:  
Research Question 1: Are social support and patient-provider communication 
associated with hypertensive African Americans self-reported medication 
adherence?  
H01: There is no significant difference in adherence to medication between 
individuals with and without social support and patient-provider 
communication.  
H11: There is a significant difference in adherence to medication between 
individuals with and without social support and patient-provider 
communication.  
I expected that there would be greater adherence to treatment by African Americans with 
higher social support and patient-provider communication.  
Research Question 2: What is the association between social support and patient-
provider communication by age among hypertensive African Americans? 
H02: There is no significant difference in the relationship between social 
support and patient-provider communication and adherence by age among 
hypertensive African Americans. 
H12: There is a significant difference in the relationship between social 
support and patient-provider communication and adherence by age among 
hypertensive African Americans. 
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I expected that there would be greater adherence to treatment for older African 
Americans with higher patient-provider communication and social support. 
Research Question 3: What is the association between social support and patient-
provider communication among hypertensive African American men and women? 
H03: There is no significant difference in adherence to medication between 
hypertensive African American men and women with or without patient-
provider communication and social support.  
H13: There is a significant difference in adherence to medication between 
hypertensive African American men and women with or without patient-
provider communication and social support. 
I expected that there would be greater adherence to treatment for African American 
women compared to men with higher patient-provider communication and social support. 
Theoretical Framework 
I used the theory of reasoned action (TRA) of Ajzen and Fishbein (1969; 1980) as 
the theoretical framework for this study. This theory is focused on the constructs of 
attitude, subjective norms and perceived control, which can be used to help explain the 
variance in behavioral intention (Glanz, Rimer, & Viswanath, 2015). Attitudes can be 
based on multiple factors, including past experiences, social support, health education 
and literacy, and the environment (Cleverism, 2018; Hackman & Knowlden, 2014). 
Subjective norms are considered the beliefs an individual has regarding whether others 
approve or disapprove of the behavior and the motivation to comply (RECAPP, 2016). 
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The TRA is further concerned with the individual motivational factors as determinants of 
the likelihood of performing a specific behavior (Hackman & Knowlden, 2014).  
 I used this theoretical construct in order to better understand how social support 
and patient-provider communication influence or motivate hypertensive African 
Americans to adhere to medication. The TRA has eight key constructs, which include 
behavior, behavioral intention, attitude, behavioral belief, evaluation, subjective norm, 
normative beliefs, and motivation to comply (Glanz et al., 2015). The more positive the 
attitude and subjective norms, the greater the perceived control and the more likely an 
individual is to comply with the intended behavior (RECAPP, 2016). The individual must 
decide to adhere to treatment in order to reduce other associated health risks. A strength 
of the TRA is that the framework provides a way to identify and measure the underlying 
reasons why a person intends to behave a particular way (RECAPP, 2016). If patients’ 
attitudes change over time through social support or patient-provider communication, 
then their behavioral intent would most likely change as well.  
Nature of Study 
In this study, I used the quantitative approach with a cross-sectional design. 
Quantitative research is a method that tests the objective theories by examining the 
relationship between the independent and dependent variables, and the data analysis is 
constrained by the type of data available (Creswell, 2009). In a quantitative approach, 
numerical data are gathered and used to generalize across a particular group of people to 
explain a particular phenomenon (University of Southern California, 2016). Moreover, 
the cross-sectional design was most appropriate for this study because I aimed to 
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determine the association between the independent and dependent variables at a single 
point in time (see Creswell, 2009). The cross-sectional design is observational and allows 
for multiple variables to be compared at the same time (Cherry, 2015). The key variables 
in this study were social support and patient-provider communication as the independent 
variables and medication adherence as the dependent variable. The covariates were 
gender, age, income, education, employment, insurance status, place of residence, the 
length of time in treatment, number of medications, and the severity of hypertension. 
Secondary Data Set 
I used a secondary data set to collect cross-sectional data for this study. Secondary 
data describes the analysis of larger data sets collected by a primary source, which allows 
studies to be conducted on high-impact research questions to further help improve the 
understanding of a public health issue (Smith et al., 2011). Likewise, secondary data are 
useful when time and resources are limited to design questionnaires and manage a large-
scale data collection project (Cheng & Phillips, 2014). One of the main goals of 
quantitative research is the concept of external validity, which involves generalizing the 
research results to a larger population (Laerd Statistics, 2012). External validity can be 
increased if the study is properly designed and there is a good representation of the 
population under study (Rothwell, 2006; Steckler & McLeroy, 2008). 
Literature Search Strategy 
I conducted a literature search for peer-reviewed journal articles to review 
empirical studies with data-based conclusions relevant to the research questions of this 
study. I searched Walden University’s data library, published dissertations, ProQuest, 
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PubMed, and Medline. The CDC data library and Google Scholar were also used to 
obtain relevant information on hypertension and medication adherence. Only peer-
reviewed journal articles published within the last 5 to 6 years were used for this research 
study. Due to limited data based on current research, I also considered peer-reviewed 
journals published within the last 9 years as relevant sources for this study if they had 
been referenced in other research studies.  
I used the following key search terms: hypertension, medication adherence, 
African Americans, high blood pressure, social support, and patient-provider 
communication. My search yielded over 100 sources in the area of hypertension, 
medication adherence, and African Americans. I reviewed over 80 articles that addressed 
the influences of patient-provider communication and social support on medication 
adherence in individuals diagnosed with hypertension and what has been shown to hinder 
or facilitate improvement blood pressure control among the target population. 
Literature Review 
Overview of Hypertension 
Hypertension, or high blood pressure, is a chronic condition that has a significant 
impact on health outcomes and health disparities (Guo, He, Zhang, & Walton, 2012). 
Hypertension exists when blood pressure is 140/90 millimeters of mercury (mmHg) or 
above most of the time (AHA, 2016). When the force of the blood flow is high, the walls 
of the arteries become stretched beyond a healthy limit, causing damage (AHA, 2016). 
According to the World Health Organization (WHO; 2016), hypertension contributes to 
9.4 million deaths worldwide every year. Economically, the burden of hypertension is 
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around $47.5 billion annually in direct medical expenses and $3.5 billion in lost 
productivity (Rajpura & Nayak, 2014).  
 According to data from the National Health and Nutrition Examination Survey, 1 
in every 3 adults in the United States aged 20 years or older suffer from hypertension 
(Rajpura & Nayak, 2014). While hypertension is a modifiable condition, if left untreated, 
it can lead to numerous health problems including heart disease, stroke, kidney failure, 
and vision loss (AHA, 2016). This condition must be detected early and treated 
appropriately in order to avoid poor health outcomes. Adherence to treatment is the 
foundation to helping control blood pressure. 
Prevalence of Hypertension Among African Americans 
The health status for African Americans in the United States lags behind that of 
other racial and ethnic groups (Martin et al., 2011). Many African Americans report a 
lack of confidence in the healthcare system, and some hold the belief that they are less 
likely to receive the same medical resources and quality of care as European Americans 
(Martin et al., 2011). Additionally, because African Americans are disproportionately 
affected by high blood pressure, the prevalence of hypertension is much higher for this 
population in comparison to European Americans or Hispanics (Lewis et al., 2012). Heart 
disease is a contributing factor for hypertension and further contributes to the morbidity 
and mortality in African Americans (Brown, 2015). The onset of hypertension tends to 
develop at an earlier age for African Americans, and its symptoms are usually more 
severe (CDC, 2016). Various barriers have caused an increase in the incidence of 
uncontrolled high blood pressure for African Americans including poverty, 
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socioeconomic status, access to medical care, a lack of health insurance, and 
nonadherence to treatment (Grant et al., 2015).  
Researchers have reported that 45% of African American men and 46% of 
African American women have hypertension, in comparison to 34% of European 
American men and 31% of European American women (CDC, 2016; Pettey et al., 2016). 
The National Health and Nutrition Examination Survey reported that only about 28% of 
African Americans with high blood pressure have it under controlled in comparison to 
33% of European Americans (Fauntleroy, 2013). Moreover, there is a greater risk of 
being diagnosed with hypertension for African Americans living in the South (Pettey et 
al., 2016). Similarly, Martin et al. (2011) found that rural African American residents had 
the worse blood pressure control in comparison to their rural and urban White 
counterparts. Even with access to free medication and a regular source of healthcare, 
rural or low-income hypertensive African American residents continue to encounter 
medication adherence barriers (Martin et al., 2011). 
Medication Adherence and Nonadherence 
Medications continue to be beneficial in saving lives for many individuals 
diagnosed with a chronic illness. Adherence to medication is an essential component of 
successful patient care and self-management of hypertension (Bosworth et al., 2011). 
Hypertensive patients are often encouraged to establish a consistent medication routine in 
their daily lives to increase adherence behaviors and to achieve optimal high blood 
pressure control rates (Solomon et al., 2015). Nonadherence to medication or treatment 
for high blood pressure is complex and challenging due to medication costs, health 
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literacy, older age, a complex routine regimen, as well as poor social support and patient-
provider communication (Marshal, Wolfe, & McKevitt, 2012).  
Nonadherence is often an unrecognized risk factor that further contributes to a 
lack of control of blood pressure for individuals diagnosed with hypertension (Oliveira-
Filho, Barreto-Filho, Neves, & Lyra Junior, 2012). Researchers have estimated that 20% 
to 50% of patients do not take their medication as prescribed (Oliveira-Filho et al., 2012). 
It has also been estimated that 125,000 deaths occur in the United States annually due to 
nonadherence to medication (Bosworth et al., 2011). Although medication adherence is a 
behavior in which people should be able to report, there has been a lack of adequate 
reliability and strong validity in self-report measures of medication adherence (Morisky 
& DiMatteo, 2011).  
Moreover, nonadherence can be categorized as intentional or unintentional if the 
given treatment advice is ignored, misunderstood, or used incorrectly (Miller & 
DiMatteo, 2013). Nair et al. (2011) conducted a qualitative study to understand the 
barriers that influenced adherence rates for hypertensive patients and found that 
unintentional nonadherence, which included forgetfulness or a lack of access to 
medications, was the primary form of nonadherence for patients with high blood 
pressure. When patients perceive that the prescribed medication is not working or has 
unwanted side effects, they may stop taking the treatment, which would be considered 
intentional nonadherence (Pettey et al., 2016; Schmitt et al., 2013). Schoenthaler, Butler, 
Chaplin, Tobin, and Ogedegbe (2016) conducted a cross-sectional study to examine the 
predictive role of key psychosocial and interpersonal factors on changes in medication 
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adherence in hypertensive African American patients. These researchers concluded that 
both patient-provider communication and social support indirectly affected medication 
adherence among patients; yet, efforts were still needed to improve adherence behaviors 
based on the patient’s medical care and the community they resided in. 
Assessment of medication adherence among African Americans. High blood 
pressure continues to increase among African Americans, and medication adherence rates 
are much lower for those who have been diagnosed with hypertension (Lewis, 2012). 
Studies have shown that antihypertensive medications have an impact on achieving 
optimal blood pressure control; yet, nonadherence to treatment has also been identified as 
a reason for poorly controlled blood pressure among African Americans (Hu, Taira, 
Yeboah, & Castillo, 2014). Conversely, documenting the adherence rates among 
hypertensive patients has been found to be difficult, and it is still not clear as to the 
factors that are associated with adherence for African Americans (Lewis, 2012). Barriers 
that affect African Americans from seeking proper treatment include poverty, low-
income, stress, religious practices, and cultural beliefs and attitudes (Brown, 2015).  
Misperceptions and a lack of understanding of the causes and treatment greatly 
influence medication adherence as well (Buis, Artinian, Schwiebert, Yarandi, & Levy, 
2014). Thus, it is imperative for African Americans diagnosed with hypertension to 
adhere to treatment to help lower the burden of heart disease morbidity and mortality and 
improve their blood pressure control. It is also important for healthcare providers to 
understand the culture of African Americans, and tailor treatment based on the particular 
needs of the patient (Brown, 2015). 
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Adherence among African American men and women. Poor adherence to 
antihypertensive medications is more pronounced in African American men than in 
women (Lewis, Schoenthaler, & Ogedegbe, 2012). African American women tend to 
have a greater awareness of their condition and are quicker to seek treatment, and 
therefore, exhibit better blood pressure control rates (Ashaye & Giles, 2003). Through a 
literature review, Lewis et al. (2012) showed that higher rates of medication 
nonadherence existed for African American men even in environments with equal access 
to care regardless of race or socioeconomic status. In another literature review examining 
factors associated with medication adherence among hypertensive African Americans, 
Lewis (2012) found that men were more likely to be nonadherent to their 
antihypertensive medications in comparison to women. On the other hand, Petty et al. 
(2012) found that females were less adherent to treatment than men due to a higher 
amount of medication and neglecting to take care. Rose, Kim, Dennison, and Hill (2000) 
conducted a qualitative study on the contexts of adherence for African Americans 
between the ages of 18 and 49 years old with high blood pressure and concluded that it 
was important for African American men to have a collaborative relationship with their 
healthcare provider, which also had a significant positive influence on their adherence to 
recommended medications. Additional researchers have shown that there is no 
association between gender and medication adherence (Lewis, 2012). These studies, 
however, were limited due to the use of self-reported data as well as a delimitation of 
only male participants. 
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Older Age and Hypertension 
Older adults may seemingly be faced with a greater challenge of adhering to 
recommended treatment when diagnosed with a chronic disease. The risk for 
hypertension increases as an individual becomes older (Holt et al., 2014). Schmitt et al. 
(2013) stated that older adults represented about 50% of multidrug users due to the 
prevalence of chronic illnesses. According to the CDC (2016), men under the age of 45 
years old are more highly affected by hypertension than women, while women over the 
age of 65 years old are more affected by high blood pressure than men. Researchers have 
shown that an estimated 40% of adults between the ages of 45 and 64 years old and 
adults over the age of 65 years old have hypertension (Warren-Findlow, Seymour, & 
Huber, 2012). Although older adults who are diagnosed with hypertension tend to have 
better control rates than younger adults, less than 50% of them have it under control 
(Cornwell & Waite, 2012; Guo et al., 2012).  
 In particular, rates of uncontrolled hypertension are higher for African American 
older adults (Cornwell & Waite, 2012). In a study on adherence behaviors among 
hypertensive African Americans followed in primary care clinics, Hekler et al. (2008) 
reported that older age was associated with better medication adherence; however, 
scholars have shown that age does not predict or influence medication adherence for 
hypertension patients. For example, Nair et al. (2011) found that differences in age did 
not appear to influence nonadherence or predict adherence reliably. Nonetheless, the 
results of this study were limited because the authors did not compare hypertensive 
patients with high adherence rates to those patients with low or moderate adherence. 
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Similarly, in a meta-analysis examining the association between age and medication 
adherence among hypertensive African Americans, the results did not show an 
association while the findings of four cross-sectional studies included in the meta-
analysis demonstrated an association between age and adherence (Lewis, 2012). Zullig et 
al. (2015) also conducted a cross-sectional analysis on self-reported medication 
adherence, race, and patient-provider communication and found that older African 
Americans reported following their health providers recommended instructions on 
medications less frequently than older European American patients. 
Attitudes Towards Medication Adherence 
Patients’ beliefs and attitudes towards medication have been shown to be 
important drivers for adherence and disease outcomes in adults (Martin et al., 2011). As 
previously mentioned, barriers to treatment adherence include the effectiveness of the 
medication, cultural perceptions and attitude, amount of social support, and the level of 
patient-provider communication (AlGhurair, Hughes, Simpson, & Guirguis, 2012). 
Pettey et al. (2016) stated that understanding the perceptions of medication adherence and 
lifestyle changes needed to treat high blood pressure could further help to provide a 
foundation for improving adherence rates among African Americans. Few empirical 
studies have focused on the perceptions of adherence to treatment among hypertensive 
African Americans. In a literature review on medication adherence in hypertensive 
African Americans, Lewis (2012) found that attitudes and illness beliefs did not have a 
significant association with medication adherence. Nonetheless, this result may have been 
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due to the limited number of extant studies found by the author and the majority being 
cross-sectional.  
Pettey et al. (2016) conducted a qualitative study to examine the perceptions of 
hypertensive treatment among African Americans between the ages of 21 and 64 years 
old. These investigators found that many of the participants had a willingness to adhere to 
their treatment but found it difficult even with free access to healthcare. Their study was 
limited by potential sample bias and longitudinal data that were not yet available at the 
time of analysis of their health because they focused on taking care of others (Pettey et 
al., 2016). Hardeman et al. (2015) conducted a quantitative study to examine the attitudes 
toward patient-centered care among African American and European American first year 
medical students. They conducted an assessment of the association between race, gender, 
and socioeconomic status with attitudes towards patient-centered care. The researchers 
concluded that status as a female medical student and a student with a low- to middle-
income socioeconomic background significantly impacted their attitudes towards patient-
centered care. Additionally, older medical students over the age of 25 also had more 
positive attitudes towards patient-centered care; however, race had no significant impact 
on their attitudes towards the topic (Hardeman et al., 2015).   
Effects of Social Support 
Social support plays a vital role in promoting better health outcomes and 
alleviating chronic diseases such as hypertension (Nurullah, 2012). According to Hatah et 
al. (2015), greater levels of social support are associated with better treatment adherence. 
Social support can come in the form of friends, family, coworkers, healthcare providers, 
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or community and faith-based organizations as perceived or received support. The 
concept of social support evaluates the interpersonal communication and relationships 
and support a patient receives from peers and medical providers (Criswell, Weber, Xu, & 
Carter, 2010). A person’s perception of social support is usually reflected by the specific 
behaviors of family and peers, which can have positive or negative effects on adherence 
to treatment (Rosland, Heisler, & Piette, 2012). Additionally, social support is useful for 
increasing patients’ perception regarding quality of life, facilitating better access to 
medical resources and utilization of healthcare services, as well as improving self-
management of hypertension. Social support from family members provides patients with 
practical help and can buffer the stresses of living with an illness (Miller & DiMatteo, 
2013). 
Empirical investigators have used three broad categories to measure social 
support: social connectedness, perceived social support, and actual social support (Kim et 
al., 2015). The most common ways to measure social support include emotional, 
instrumental, and information support. Emotional support is defined as an individual 
having another person in his or her life to provide empathy, and someone that can be 
trusted (Johnson, Jacobson, Gazmararian, & Blake, 2010). Informational support 
describes having someone to help with reading written materials obtained from a 
physician or hospital. Moreover, instrumental support, also known as tangible support, 
includes the provision of material aid such as giving information to understand a situation 




In a systematic review conducted on the impact of family behaviors and 
communication patterns on chronic illness outcomes, the results found that family 
encouragement and cohesion were associated with improved outcomes for individuals 
diagnosed with hypertension (Rosland et al., 2012). These researchers also found that 
general social support had a stronger effect for women than men. Moreover, Schoenthaler 
et al. (2016) found that functional social support rather than structural social support was 
an important aspect to adherence of antihypertensive medications. In a qualitative study 
conducted by Petty et al. (2016), 53% of the respondents reported that family support 
such as a mother or sister, was the most important, as well as hearing stories about family 
and friends with certain health complications facilitated their decision to seek care or 
adhere to treatment.  
Studies have also been conducted to show the effects of culture and religion on 
social support and medication adherence. African Americans tend to have higher levels 
of religious involvement, and church is usually the foundation of the community (Holt et 
al., 2014). Religious involvement is a way to facilitate social support and provide a sense 
of belonging, as well as, cohesiveness. In the cross-sectional study conducted by Hatah et 
al. (2015), the researchers evaluated the influence of cultural orientation and religiosity of 
patients with chronic diseases including hypertension on social support and adherence to 
medication. The researchers found that while age, duration of treatment, and faith-based 
activity had significant influence on adherence to treatment, there was no significant 
association between social support and medication adherence. Holt et al. (2014) 
performed a qualitative study to assess the role of social support and the relationship of 
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religious involvement and physical and emotional functioning among African Americans 
and health outcomes. Holt et al. concluded that tangible social support was associated 
with religious behaviors and improving medication adherence. 
The impact of social support can influence the ability of an individual to make 
lifestyle adjustments that would help them to live with hypertension and make positive 
behavioral changes. A randomized clinical trial was conducted by Bokhour et al. (2016) 
to assess the impact of viewing African American patients’ stories of successfully 
controlling hypertension on intention to change self-management behaviors, as well as, 
engagement with educational materials. The study sample included 618 African 
American veterans with uncontrolled blood pressure who viewed information-only DVDs 
about hypertension or a DVD with African American veterans telling stories about 
successfully managing their blood pressure. The results demonstrated that videotaped 
patient’s stories was not only an effective way of communication but also influenced 
other hypertensive patient’s intentions to change their health behaviors affecting blood 
pressure control (Bokhour et al., 2016). The use of story sharing was a way to increase 
social support and peer interventions that could further help patients adhere to their 
medications. These authors also found that patients were more likely to communicate 
with their doctors after viewing the stories (Bokhour et al., 2016). Nevertheless, the study 
was limited to focusing on patients’ intention to change their health behaviors but may 
not have resulted in actual change.  
Social support through family and community members has been shown to be 
influential in African Americans decisions to adherence to hypertensive treatment; yet, 
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the extent of this influence is still not completely understood (Pettey et al. 2016). Social 
support can have a negative impact and become a barrier to self-management of 
hypertension. For example, in a literature review conducted by Miller and DiMatteo 
(2013), the investigators found that social support had been linked to adverse health 
outcomes and suggested that some patients felt criticized, nagged, or guilty when 
receiving support from family. The sabotaging behavior created conflict due to an 
increase in family involvement and undermined the success of an individual adhering to 
medication. Lewis et al. (2012) also found that social support did not appear to be 
consistently associated with medication adherence in hypertensive African Americans. 
Braverman and Dedier (2009) used an electronic cap to measure medication adherence 
and found that social support was not associated with adherence.  
Patient-Provider Communication and Care 
Communication skills are fundamental in healthcare, in particular between the 
provider and the patient. Patient-provider communication is multidimensional and can 
have an impact on patients’ decision to adhere to their medication (Levinson et al., 2010; 
Schoenthaler et al., 2009). Patients tend to rely on their healthcare provider as the 
primary source of information when discussing medical care and treatment options 
(Lewis et al., 2012). The provider usually asks the patient various questions to assess the 
best medical treatment that would meet patients’ needs for their particular health 
condition such as hypertension. Patients who communicate with their healthcare provider 
have the ability to express how they feel about their health, medical treatment, and 
making healthier lifestyle choices; however, healthcare providers have been found to lack 
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skills in identifying poor medication adherence among their African American patients. 
For example, in a study about young, urban hypertensive African Americans, the authors 
estimated that 60% of the time, the health provider was unable to identify poor mediation 
adherence (Braverman & Dedier, 2009).  
Moreover, trust in a provider is synonymous with adherence to treatment. Patient-
provider communication is one way to establish trust and encourage individuals to 
become more involved in decisions regarding their health (Martin et al., 2011). Equally, 
the trust built through patient-provider communication can be associated with better 
satisfaction with healthcare, an increase in treatment adherence, as well as, improved 
health outcomes. Abel and Efird (2013) stated that patients’ trust in their health provider 
implies confidence that the provider’s words are honest, and actions are appropriate in the 
provision of care and treatment. Lower levels of trust in health providers are also 
associated with lower patient satisfaction and treatment adherence among racial minority 
populations, including African Americans (Martin et al., 2011). 
African Americans are less likely to seek or receive needed health services, 
procedures, or routine treatments for hypertension in comparison to White Americans 
(Martin et al., 2011). Researchers have further suggested that African American patients 
report poor quality of interactions with healthcare providers (Greer, Brondolo, & Brown, 
2014). Abel and Efird (2013) found that hypertensive African American women who 
trusted their health providers were more likely to be adherent to treatment versus those 
who did not trust their providers. The lack of trust and communication can also increase 
health disparities among races. The distrustful relationships between African Americans 
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and healthcare providers have also been influenced by past historical events such as the 
Tuskegee experiment. Throughout history, African Americans were frequently used in 
experiments by White doctors to help improve medical and surgical techniques before 
attempting the same procedures on Whites, thus causing distrust (Abel & Efird, 2013). 
Likewise, patients who engage in decision-making with their healthcare provider 
are not only more likely to be satisfied with the quality of care but are also likely to 
adhere to recommended treatment (Aseltine, Sabina, Barclay, & Graham, 2016; 
Schoenthaler et al., 2009). Several barriers, however, interfere with adherence to 
hypertensive treatment including a lack of knowledge and understanding of a provider’s 
recommendations. Patient-provider communication can also be a complex process due to 
unrealistic patient expectations, nondisclosure of information, or a lack of sensitivity for 
the patient (Schoenthaler et al., 2012). Furthermore, healthcare providers are unable to 
accurately assess their patients’ perceptions of their care, what is important to them, nor 
how well the care is being delivered (Rickert, 2012).  
Similarly, African American patients may receive marked differences in the 
quality of patient-provider communication due to their race (Aseltine et al., 2016). Thus, 
racial differences also create a barrier to patient-provider communication. For instance, 
reports have shown that hypertensive African American patients receive suboptimal 
communication with providers and higher levels of unmet information needs (Lewis et 
al., 2012). In comparison to White Americans, communication for some African 
American patients was less informative and supportive, as well as, less participatory. 
Some healthcare providers perceived hypertensive African American patients as less 
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effective communicators, treated them contentiously, and did not use patient-centered 
communication. On the other hand, African American patients perceived their provider as 
disrespectful and provided unfair treatment, thus leading to a decrease in using health 
services and adherence to treatment.  
Three main goals of patient-provider communication include developing an 
interpersonal relationship, facilitating the exchange of information, and involving patients 
in decisions making (Ha, Anat, & Longnecker, 2010). Miscommunication, however, can 
cause complications between the patient and healthcare provider that could hinder 
patients’ understanding, expectations of treatment, or involvement in the medical 
decisions. Miscommunication also decreases patients’ satisfaction with the quality of 
medical care (Ha et al., 2010). Doctors who avoid discussing patients’ problems or 
discourage patients from voicing their concerns are additional barriers to medication 
adherence and patient-provider communication. 
 According to the Agency for Healthcare Research and Quality (2014), 40%–80% 
of the medical information patients are given during an office visit is forgotten 
immediately or nearly half of the information retained is incorrect. Patients who lack a 
clear understanding of their health condition will more than likely not make a follow-up 
appointment or risk being readmitted to the hospital. Collaborative patient-provider 
communication increases the likelihood of a patient adhering to their antihypertensive 
medication, especially for African Americans (Schoenthaler et al., 2016). The process of 
communication can significantly depend on preexisting, shared cultural patterns, and 
social structures (Lewis et al., 2012). Like social support, the role and influence of 
27 
 
patient-provider communication is not clearly understood among African American 
hypertensive patients (Schoenthaler et al., 2016). 
Definition of Terms 
Hypertension: This is a term used to describe high blood pressure (Rajpura & 
Nayak, 2014). 
Medication adherence: The extent to which a patient follows a given medication 
regimen as agreed on in partnership with a healthcare professional (AlGhurair, Hughes, 
Simpson, & Guirguis, 2012) 
Medication nonadherence: The extent to which patients do not follow treatment 
recommendations given by their health providers, either willfully or inadvertently (Miller 
& DiMatteo, 2013; Rajpura & Nayak, 2014).  
Patient-provider communication: An increase in health providers’ understanding 
of patients’ individual values, needs, and perspectives that allows patients to actively 
participate in decisions regarding their health and healthcare (Levinson et al., 2010; 
Zulling et al., 2015). 
Social support: The exchange of resources between two individuals perceived by 
the provider or the recipient to be intended to enhance the well-being of the recipient; 
assets that an individual is provided through their social ties (Hatah et al., 2015; Holt et 
al., 2014). 
Uncontrolled blood pressure: A persistent elevation of systolic blood pressure of 





I assumed that participants self-identified as African American. I also assumed 
that participants truthfully answered questionnaires to the best of their ability and on their 
own. Finally, I assumed that the material presented in the surveys was understood and 
relevant to the participants’ life condition. 
Scope and Delimitations 
It was within the scope of this doctoral study to address the significance of 
patient-provider communication and social support on the influence of attitudes towards 
medication adherence in hypertensive African American patients. Poorly controlled 
hypertension due to nonadherence to antihypertensive medication continues to remain a 
significant public health issue in the United States, and specifically among African 
Americans (Schoenthaler et al., 2012). The study was delimited to African American men 
and women between the ages of 21–65 years, born in the United States, who speak fluent 
English, and have at minimum a high school education. Participants were required to be 
diagnosed with hypertension and were required to be taking at least one antihypertensive 
medication. Participants had to self-identify as African American. A secondary data set 
was used to collect information on selected participants related to the measuring variables 
for this study. By using secondary data, the quality of data, data collection, and available 
measuring instruments was limited to what was obtained in the primary research study. 
Significance of Social Change Implications 
Adherence to hypertension treatment is essential to controlling blood pressure as 
well as decreasing other health complications. Medication adherence is significantly 
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important for African Americans because they have a disproportionately greater burden 
of cardiovascular disease morbidity and mortality rates than any other ethnic group in the 
United States (Solomon et al., 2015). Thus, there is a need for enhanced patient-provider 
communication so that African Americans can learn to properly manage their blood 
pressure (Solomon et al., 2015). Treatment can then be tailored to meet the particular 
needs of patients based on their level of health knowledge.  
Likewise, through social support, the creation of effective support groups can 
develop positive change by helping to promote adherence to medication and healthy 
living (Vaccaro et al., 2014). It is imperative for the healthcare community to identify 
barriers to medication adherence and develop efficient ways to engage African American 
men and women in programs to improve their hypertension control (Nair et al., 2011). 
Improvement of hypertension-related knowledge is an important strategy for increasing 
medication adherence (Zulling et al., 2013); however, no particular intervention for 
improving medication adherence in hypertensive individuals has emerged as the universal 
standard for improvement. (Lewis et al., 2012). 
There is still a need to identify strategies to sustain adherence over time and create 
social change in health behaviors of African Americans with uncontrolled blood pressure 
(Lewis et al., 2012). The findings of this study could provide insight for healthcare 
providers to improve patient-provider communication among hypertensive African 
Americans by adapting better cultural sensitivity, which can help improve the attitudes 
towards self-management of health behaviors. This may also lead to an increase in better 
health outcomes and reduce chronic illnesses, hospitalizations, and associated diseases 
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(Aseltine et al., 2016). Furthermore, the results of this study could provide an 
understanding on how the impact of social support, through family, friends, and 
community sources can help prevent patient isolation in dealing with chronic health 
conditions. Thus, hypertensive African Americans could establish a more positive 
attitude about their health and develop better adherence to recommended treatment. 
Conclusion 
In Section 1, I illustrated how TRA was used as a foundation for this research 
investigation. In Section 1, I also provided an outline regarding the high prevalence of 
hypertension among African American men and women and why it has become a public 
health concern. Previous scholars have shown the importance of adhering to medication 
to improve health outcomes for patients diagnosed with hypertension. African Americans 
continue to be disproportionately affected by high rates of uncontrolled blood pressure 
and have lower rates of medication adherence. Patient-provider communication and 
social support are necessary factors to help improve blood pressure control and rates of 
adherence to medication among hypertensive African Americans; yet, studies are limited, 
have been inconclusive, or have varied according to gender and age in understanding the 
influence social support and patient-provider communication have on the attitudes of 
hypertensive patients towards medication adherence. Therefore, further research is 
warranted to obtain these findings. In Section 2, I will describe the research design and 
rationale of the doctoral study, including a brief description of the secondary data set that 
I used to collect data for analyzation. I will also discuss the methodology, including 
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Section 2: Research Design and Data Collection 
Introduction 
The purpose of this doctoral study was to examine the association between social 
support and patient-provider communication towards medication adherence for both 
hypertensive African American men and women between the ages of 21 and 65 years old 
in the United States. This section will include an overview of the quantitative cross-
sectional design of the study, the rationale for choosing such a design, and the sampling 
method used. In Section 2, I will also discuss the sampling frame, the methods used for 
data collection, and the variable measuring instruments. Furthermore, I will briefly 
describe the Counseling African Americans to Control Hypertension (CAATCH) clinical 
trial study from which the secondary data were obtained. Data from the CAATCH study 
were collected between 2004 and 2011. Finally, I will describe the data analysis 
procedures, threats to internal and external validities, and ethical considerations of the 
study. 
Research Design and Rationale 
I used a quantitative cross-sectional design with a secondary data analysis as the 
approach for this study. In a cross-sectional study, data are collected at a single point in 
time to examine the relationship between the disease, such as hypertension, and other 
variables of interest (Cherry, 2015). Additionally, a cross-sectional study can provide a 
snapshot of various health-related characteristics or frequency of a disease for a defined 
population. An advantage to conducting a cross-sectional study is that information can be 
gathered quickly and in a less expensive manner than other designs (Cherry, 2015). A 
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cross-sectional study allows multiple factors, including exposure, outcomes, and 
confounders, to be examined simultaneously (Cherry, 2015). Moreover, I used a 
secondary data set that contained the variables and measuring instruments related to this 
doctoral study. It was not my goal to interview or observe participants in their natural 
setting. Likewise, due to time constraints in designing the study and collecting primary 
data, use of a secondary data set was appropriate for this study. 
Study Variables 
The design that I chose for this study allowed for the assessment of the 
relationship between the independent and dependent variables. I focused on two 
independent or predictive variables, which were patient-provider communication and 
social support. The dependent or outcome variable was medication adherence among 
hypertensive African Americans. The covariate variables included gender, age, income, 
education, employment, insurance status, and place of residence. The length of time in 
treatment, number of medications, and the severity of hypertension were also used as 
moderating variables. Using these particular demographics allowed me to generalize the 
findings to a broader population (see Ogedegbe et al., 2014).  
Methodology 
Population 
The target population for this doctoral study was hypertensive African American 
men and women between the ages of 21 and 65 years old. A total of 1,039 patients over 
the age of 18 years old were enrolled in the study who self-identified as African 
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American with uncontrolled hypertension (Ogedegbe et al., 2014). From this population, 
I selected the sample participants. 
Setting and Sampling Method 
I identified a cluster-randomized clinical trial known as the CAATCH trial as the 
appropriate secondary data set to use for this doctoral study. The CAATCH study is 
considered the largest, practice-based, implementation trial of a multilevel, evidence-
based intervention targeted towards blood pressure control in hypertensive African 
Americans and represented the best source of data for this research study (see Ogedegbe 
et al., 2014). A total of 1,039 patients over the age of 18 years old were enrolled in the 
study who self-identified as African American with uncontrolled hypertension 
(Fernandez et al., 2011). The patients were chosen from 30 community health centers 
where they received care and randomly assigned to the intervention condition or usual 
care condition (Fernandez et al., 2011). Patients were recruited through letters from their 
primary care clinicians (Ogedegbe et al., 2014). Random sampling can help to ensure that 
every sampling unit of the population has an equal chance of being included in the 
sample (Frankfort-Nachmias & Nachmias, 2008). An advantage to using random 
sampling is the potential to reduce selection bias (Laerd Statistics, 2012). The CAATCH 
study protocol was approved by the institutional review boards of Columbia University, 
New York University, and the Clinical Directors Network (Ogedegbe et al., 2014). I 
obtained permission to access the data set through an e-mail sent to the original 




I determined the sampling frame based on the inclusion and exclusion criteria 
from the primary study. Participants who met the original demographic and inclusion 
criteria were also eligible for this study. In the following subsections, I will detail these 
criteria. 
Inclusion. The participants were required to self-identify as African American 
and be between the ages of 21 and 65 years old. The participants were required to speak 
fluent English and be receiving care at the community health center for more than 6 
months. The participants were required to have received a diagnosis of hypertension and 
uncontrolled blood pressure since their last office visit. Lastly, the participants were 
required to be on at least one antihypertensive medication. 
Exclusion. Participants were excluded if they did not speak English and were 
unable or unwilling to complete screening or baseline assessment. Participants were also 
excluded if they had already participated in a hypertensive clinical study. The participants 
could not have an arm circumference greater than 42cm. 
Data Collection Method 
I collected data for this doctoral study through surveys that were administered 
originally in the CAATCH study. A survey is an instrument used to collect verifiable 
information, and usually requires a respondent to choose from a scale (Center for 
Research Quality, 2015). Surveys are also useful for collecting self-reported information 
on hard-to-measure variables. Data and study measurements were previously gathered by 
trained research assistants at baseline and every 3 months for 12 months, with a follow-
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up 24 months later (Schoenthaler et al., 2016). Participants for the original study were 
recruited via letters from their primary care doctors at community health centers 
(Ogedegbe et al., 2014). All enrolled patients provided written informed consent (see 
Ogedegbe et al., 2014). I selected participants for this doctoral study from the CAATCH 
trial data set based on their responses to sociodemographic data and survey questions 
related to the measuring variables of this study. Demographic data included gender, age, 
employment status, insurance status, education, and income level. I gained access to the 
secondary data set through a permissions e-mail that I sent to the original researchers. 
Power Analysis 
I used a power analysis in this quantitative research study to help determine the 
sample size. Performing a power analysis and sample size calculation is an important 
aspect of a research design to avoid the sample size from being too small or too large to 
detect any significant differences between groups (Statistic Solutions, 2017). Power 
refers to the probability of achieving a significant result if the null hypothesis is false 
(UCLA Statistical Consulting Group, 2017). The probability also increases as the sample 
size gets larger (McDonald, 2014). Moreover, the statistical power is dependent on the 
effect size, which can be small, medium, or large (UCLA Statistical Consulting Group, 
2017). For example, larger effect sizes require smaller samples sizes to have the same 
power, while smaller effect sizes require larger samples to have enough power (Sullivan 
& Feinn, 2012). The most commonly used power level is 0.80, with an alpha of 0.05 to 
achieve the desired level of significance (UCLA Statistical Consulting Group, 2017). I 
used the G*Power software as the statistical tool to calculate the sample size for this 
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doctoral study. I anticipated that a minimum sample size of 248 participants would be 
needed to test statistical significance for the study. The sample size was calculated using 
binomial logistic regression statistical model with a two-tailed test, an alpha of 0.05, and 
0.80 power. The effect size was set to 0.3. Based on these projections, a sample size of 
248 was deemed adequate for detecting a medium effect size for Hypotheses 1 and 2. 
Instrumentation 
Measuring instruments had already been developed and validated within the 
original CAATCH trial study, so I tailored these instruments for this research study. The 
instruments that I used in this doctoral study included the Morisky Medication Adherence 
Scale (MMAS), the Social Support Scale, and the Physician Communication Style 
Survey. Table 1 provides a brief summary of the operationalization of variables that I 






Operationalization of Variables 
Variable Brief Description Data Category Measure 
Adherence 
 
Adherence to prescribed 
medication 
Binary    0 = Nonadherent 






Continuous Questionnaire (Bultman & 
Svarstad, 2000) 
Social Support Social Support Continuous Medical Outcomes Study 
(MOS) Social Support Survey 
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          0 = Male   
          1 = Female 
 
      0 = Never married 
          1 = Married 
          2 = Divorced 
          3 = Separated 
          4 = Widowed 
 
          0 = None 
          1 = Grades 8 
          2 = Grade 9 
          3 = High School 
   4 = Technical School 
          5 = Some College 
          6 = Associates 
          7 = Bachelors 
          8 = Graduate School  
         (Masters or Above) 
 
     0 = No 
     1 = Yes 
 
     0 = less than $25,000 
     1 = ≥ $25,000 
 
     0 = No 
     1 = Yes 
    
 
Morisky Medication Adherence Scale (MMAS) 
In this study, I assessed medication adherence using the MMAS, a psychosocial 
measure used in the CAATCH trial study. The MMAS is an indirect method of 
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measurement, and it includes a structured self-reported questionnaire used to assess the 
behavior of medication adherence for patients diagnosed with chronic illnesses, such as 
hypertension (Morisky & DiMatteo, 2011). In 2008, the scale was updated to an 8-item 
measure (MMAS-8), which has been shown to have high reliability and validity. For 
instance, in a study conducted by Oliveira-Filho et al. (2012), the MMAS-8 was used to 
measure medication adherence and demonstrated good potential as a screening tool in 
clinical practice to identify nonadherent patients and those at risk of uncontrolled blood 
pressure. The scale further demonstrated excellent internal consistency with the 
Cronbach’s α of 0.90 using inner-city patients with hypertension (Shea, Misra, Ehrlich, 
Field, & Francis, 1992).  
The MMAS is an 8-item instrument with dichotomous answers that are designed 
to avoid a bias of positive responses from patients when responding to health 
professionals (Schoenthaler et al., 2009; Schoenthaler et al., 2012 ). Questions 1 through 
7 have “yes” or “no” responses, while Question 8 has a 5-point, Likert response scale (De 
las Cuevas & Peñate, 2015). The total scores on the MMAS-8 range from 0 to 8 to 
demonstrate the continuous levels of adherence (De las Cuevas & Peñate, 2015; Oliveira-
Filho et al., 2012). A high score between 7 and 8 points represents high adherence, while 
a score below 6 points corresponds to less adherence to medication. The scale is also 
useful in better understanding behaviors related to medication use that may be 




Physician Communication Style 
I assessed patient-provider communication with a measuring instrument that 
originated from a study assessing the effect of physicians’ initial and follow-up 
communication styles on beliefs and behaviors of patients with depression (see 
Schoenthaler et al., 2009). This communication instrument uses concepts from the health 
communication model and evaluates a patient’s perception of the quality of their 
physicians’ communication style as well as the extent to which the physician encourages 
patient participation in treatment process (Schoenthaler et al., 2012). The 13-item 
communication scale, also used as a measuring instrument in the CAATCH trial, was 
appropriate for this doctoral study because it focuses on how physicians monitor patients’ 
medication use, which is an important component in having a collaborative patient-
provider relationship. 
The first 11 questions are based on a Likert-type scale. Questions include: “To 
what degree was your doctor: 1 = friendly during the visit?” and “To what extent did your 
doctor: 2 = ask if you had questions and concerns?” The total scores for the survey range 
from 1 to 4 with higher scores corresponding to better communication (Lewis et al., 
2012; Schoenthaler et al., 2012). Additionally, the communication scale has been used in 
a study that evaluated the effects of patients’ perceptions of health providers’ 
communication on medication adherence in hypertensive African Americans 
(Schoenthaler et al., 2009). These researchers found the scale valid and reliable with a 
reported Cronbach’s alpha of .92. 
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Medical Outcome Study – Social Support Survey (MOS-SS) 
I measured social support using the Medical Outcome Study Social Support 
Survey (MOS-SS), another measuring instrument used in the CAATCH trial. The survey 
was developed for patients with chronic conditions, including hypertension, in the MOS 
(Grant et al., 2015; Moser et al., 2012; Sherbourne & Steward, 1991). The survey is a 19-
item, self-administered questionnaire that measures multidimensional functional 
characteristics of the availability of perceived social support (Grant et al., 2015. The four 
domains of functional support covered within the questionnaire include 
emotional/informational support, tangible or instrumental support, positive social 
interaction, and affection (Grant et al., 2015; Schoenthaler et al., 2016). The survey uses a 
5-point, Likert scale. Questions include: “How often is each of the following kind of 
support available to you if you need it?” and “Someone you can count on to listen to you 
when you need to talk.”  The overall social support score is measured by obtaining the 
average of the mean scores of the four domains or subscales (Schoenthaler et al., 2016). 
The MOS-SS is scored using the formula 100 x (observed score-minimum) / (maximum-
minimum); this formula is used for getting total and subscale scores (Moser et al., 2012; 
Sherbourne & Steward, 1991). Moreover, the MOS-SS has response options ranging 
between 1 and 5; a higher score corresponds with greater social support (Grant et al., 
2015).  
The MOS-SS survey is a widely used, short, simple, and easy-to-understand 
measuring instrument that has been administered to cancer patients and chronically ill 
patients of all ages. Additionally, the instrument has been found to be valid and reliable. 
42 
 
For example, in the 2-year study of patients with chronic conditions conducted by 
Sherbourne and Stewart (1991) to better understand the various functions of social 
support, the MOS-SS was found to have a construct validity of 0.88. Internal-consistency 
reliability was also tested, and Cronbach’s alpha showed tangible support of 0.92; 
emotional support scale of 0.96, affection of 0.91, positive interaction of 0.94; and overall 
support index of 0.97. In another study that examined and validated the psychometric 
properties of a modified MOS-SS in two populations of women with breast cancer, 
Moser et al. (2012) showed both internal reliability and construct validity to be good. 
Research Questions and Hypotheses 
Through this research study, I aimed to answer the following three questions by 
evaluating their associated hypotheses: 
Research Question 1: Are social support and patient-provider communication 
associated with hypertensive African Americans self-reported medication 
adherence?  
H01: The null hypothesis states that there is no significant difference in 
adherence to medication between individuals with and without social 
support and patient-provider communication.  
H11: The alternative hypothesis states that there is a significant difference 
in adherence to medication between individuals with and without social 
support and patient-provider communication.  
Research Question 2: What is the association of social support and patient-
provider communication by age among hypertensive African Americans? 
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H02: The null hypothesis states that there is no significant difference in the 
relationship between social support and patient-provider communication 
and adherence by age among hypertensive African Americans. 
H12: The alternative hypothesis states that there is a significant difference 
in the relationship between social support and patient-provider 
communication and adherence by age among hypertensive African 
Americans. 
Research Question 3: What is the association of social support and patient-
provider communication among hypertensive African American men and women? 
H03: The null hypothesis states that there is no significant difference in 
adherence to medication between hypertensive African American men and 
women with or without patient-provider communication and social 
support.  
H13: The alternative hypothesis states that there is a significant difference 
in adherence to medication between hypertensive African American men 
and women with or without patient-provider communication and social 
support. 
Data Analysis 
Data were analyzed and interpreted using the Statistical Package for the Social 
Sciences (SPSS) software, Version 25 (IBM Corp, 2012). Univariate analysis, which 
includes the frequency and percentage distributions, was used to describe 
sociodemographic characteristics of the study participants, physician communication 
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style, and adherence variables. Through this analysis, I determined whether all data met 
the appropriate assumptions. The mean and standard deviation were reported for ratio and 
interval variables. Missing data were automatically excluded by SPSS when the logistic 
regression model was created.   
Furthermore, because the dependent variable was binary, a binomial logistic 
regression analysis was conducted to address the three research questions since the 
dependent variable in each of the different research questions which was adherence to 
medication is a binary variable. A binomial logistic regression predicts the probability 
that an observation falls into one of two categories of a dichotomous dependent variable 
based on one or more independent variables that can be either continuous or categorical 
(Statistics Solutions, 2017). In addition, a hierarchical form of the logistic regression was 
used to control for confounders in all logistic regression models created. Hierarchical 
logistic regression analysis is conducted when the dependent variable is dichotomous or 
has two categories and is useful as a model-building technique in any regression model 
by adding more predictors (Statistics Solutions, 2017). Furthermore, hierarchical 
regression is a way to show if variables of interest explain a statistically significant 
amount of variance in the dependent variable after accounting for all other variables.  
Unadjusted and adjusted hierarchical logistic regression models were estimated 
and compared to evaluate and control for the potential effect of confounders including 
age, gender, income, education, marital status, employment, and health insurance that 
have been shown to influence medication adherence. Two blocks in the regression model 
were used for the unadjusted results. The first block included the control variables or 
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covariates. The second block controlled the effects of these covariates while determining 
the impact of the independent variables which are social support and patient-provided 
communication on medication adherence. The Likelihood Ratio test was used to test 
whether all predictor variables in a model are simultaneously zero, and the Wald test was 
used to test whether particular predictor variables in a model are zero. Predictors that are 
significantly associated (p < 0.05) with the dependent variable were included in the 
model, and dropped from the model otherwise. Comparing the unadjusted and adjusted 
hierarchical logistic regression helped to provide the best possible estimate of the impact 
of the primary predictors while controlling for or reducing bias. The resulting model 
helped me to estimate the adjusted odds ratio to explain the strength of the association 
between the independent variables of patient-provider communication and social support, 
and the dependent variable of medication adherence, while adjusting for potential 
confounders. 
I interpreted the results using a two-tailed test with a confidence interval of 95%. 
To determine the statistical significance, the null hypotheses was rejected if p < 0.05. 
Measures of central tendency and dispersion were used to identify skewness of the data, 
outliers or leverage points. The fit of the models was evaluated using a modified version 
of the Hosmer-Lemeshow test. The modified Hosmer-Lemeshow test treats the 
multinomial model as if it were a set of independent ordinary logistic regressions models 
of each outcome against a reference group and tests the fit for each independent model 
separately (Statistics Solutions, 2017). 
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Threats to Validity 
Validity is necessary to ensure that what is intended on being measured within the 
study is actually being measured. Internal and external validity can influence the study 
results and findings. Internal validity refers to ability to make casual inferences about the 
target population (Creswell, 2009). Conversely, external validity is the extent to which 
the results can be generalized to a larger population (Frankfort-Nachmias & Nachmias, 
2008). This doctoral study was limited by threats to internal and external validities. A 
potential threat to internal validity for this study was the measuring instrumentations. 
Effective changes in instrumentation can have an impact on the outcome scores 
(Creswell, 2009; Datt, 2016). Therefore, the same measuring instruments used to collect 
data in the original CAATCH trial were used for this study that relate to this study’s 
research variables. The measuring instruments being used in this doctoral study not only 
aligned with the theoretical framework, but have been previously established as reliable 
and valid. 
Another potential threat to internal validity was the attrition rate. The attrition rate 
refers to the mortality or drop-out rate among participants, which can lead to incomplete 
outcome data (Datt, 2016). According to Ogedegbe et al. (2014), the CAATCH trial had 
an attrition rate of 30%; hence, the data for this study were weighted in order to be 
representative of the population being examined. Moreover, the external validity of the 
current study may be limited by the representativeness of the sample. The focus of the 
study was on African Americans between the ages of 35–65 years. Obtaining a good 
representativeness of the sample can be addressed through the specific inclusion and 
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exclusion criteria, as well as using participants who have complete data on the measures 
being examined. Participants for the study reflected the characteristics of the target 
population based on such criteria and can potentially be representative of other 
hypertensive African American patients. 
Ethical Considerations 
This doctoral study presented no risk to study participants. No physical 
experimentation was performed. Participants were subject to questionnaires and surveys 
only. Additionally, participants’ names and personal information were excluded from the 
surveys. As previously stated, permission to use data for the study was obtained by a 
written e-mailed letter to the original researchers. All data remained anonymous and 
participants were identified by a generic code. Data were treated with extreme 
confidentiality and stored on a secure and encrypted flash drive. Only myself and a 
statistician had access to the secondary data. Official approval to collect data for this 
doctoral study was granted from the Walden University Institutional Review Board office 
(Approval # 07-18-18-0542557). 
Summary 
In this doctoral study, I used a quantitative cross-sectional design and collected 
data from a secondary data set. The target population for the study focused on 
hypertensive African American men and women between the ages of 21–65 years. 
Participants were randomly selected using characteristic as specified in the sampling 
frame. Moreover, survey instruments were used for data collection. The G*Power 
software was also used to calculate the sample size, and SPSS software was used for data 
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analysis. In Section 3, I will discuss the data collection of the secondary data set. In 




Section 3: Presentation of the Results and Findings 
Introduction 
The purpose of this quantitative cross-sectional study was to examine the 
association between social support and patient-provider communication related to 
medication adherence for hypertensive African American men and women between the 
ages of 21–65 years old in the United States. The independent variables in this study were 
patient-provider communication and social support, while the dependent variable in this 
study was adherence to prescribed medication among hypertensive African Americans. 
The covariates in this study were age, gender, marital status, education, employment, 
income, and insurance. I conducted descriptive statistical analysis and hierarchical 
logistic regression analysis to address the objectives of the study and used SPSS to run 
the different statistical analyses. Specifically, the following research questions and 
hypotheses were tested in the quantitative analysis: 
Research Question 1: Are social support and patient-provider communication 
associated with hypertensive African Americans self-reported medication 
adherence? 
H01: There is no significant difference in adherence to medication between 
individuals with and without social support and patient-provider 
communication.  
H11: There is a significant difference in adherence to medication between 




Research Question 2: What is the association between social support and patient-
provider communication by age among hypertensive African Americans? 
H02: There is no significant difference in the relationship between social 
support and patient-provider communication and adherence by age among 
hypertensive African Americans. 
H12: There is a significant difference in the relationship between social 
support and patient-provider communication and adherence by age among 
hypertensive African Americans. 
Research Question 3: What is the association between social support and patient-
provider communication among hypertensive African American men and women? 
H03: There is no significant difference in the relationship between social 
support and patient-provider communication and adherence between 
hypertensive African American men and women. 
H13: There is a significant difference in the relationship between social 
support and patient-provider communication and adherence between 
hypertensive African American men and women. 
Data Collection 
The target population in this study consisted of hypertensive African American 
men and women between the ages of 21 and 65 years old. I used secondary data in this 
study from the survey administered originally in the CAATCH clinical trial study. Data 
from the CAATCH study were collected between 2004 and 2011. The CAATCH study is 
considered the largest, practice-based, implementation trial of a multilevel, evidence-
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based intervention targeted towards blood pressure control in hypertensive African 
Americans (Ogedegbe et al., 2014). In the CAATCH, the African American patients with 
uncontrolled hypertension were chosen from 30 community health centers where they 
received care and randomly assigned to the intervention condition or usual care condition 
(Ogedegbe et al., 2009). Patients were recruited through letters from their primary care 
clinician (Ogedegbe et al., 2014). 
For this study, the minimum required number of sample participants was 248, 
based on the results of a power analysis. Initially, I obtained a total of 1,059 samples but 
removed 493 (48.5%) samples that did not meet the inclusion criteria of this study. Those 
excluded from the final data set were not African American or did not fit within the 
inclusion criteria for age (i.e., between the ages of 21 and 65 years old). Specifically, 
among these 493 samples that were removed, 19 (1.88% of the total sample) were aged 
less than 21 years old, 249 (23.5% of the total sample) were aged greater than 65 years 
old, and 225 (21.2% of the total sample) were not African American. The final number of 
samples of the study consisted of 566 (51.5% of the total sample) hypertensive African 
American men and women between the ages of 21 and 65 years old. The final number of 
566 participants was acceptable because it was more than the requirement of 248 
participants deemed necessary by the power analysis. 
Demographic Information 
I considered the demographic data as covariates in this study. The demographic 
information included age, gender, marital status, education, employment, income, and 
insurance. Table 2 displays the demographic information of the sample population. The 
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mean age of the 566 hypertensive African American men and women was 51.91 years old 
(SD = 8.66). Concerning gender, more than half of the 566 samples of hypertensive 
African Americans were females (n = 381, 67.3%). The majority of the sample were not 
of Hispanic origin (n = 545, 96.3%). For marital status, the majority of the participants 
were never married (n = 208, 36.7%), while 135 (23.9%) were married. For education 
level, the top three highest degrees or levels of school completed were high school (n = 
182, 32.2%), Grade 9 (n = 154, 27.2%), and some college (n = 120, 21.2%). For 
employment status, only 193 (34.1%) out of the 566 participants were employed. For 
insurance, more than half of the sample reported having Medicaid (n = 341, 60.2%). For 
income, a majority of the 566 participants were in the low-income group (n = 491, 
86.8%). 
Table 2 
Frequency and Percentage Summaries of Gender, Marital Status, Education, 
Employment, Insurance, and Income 
  Frequency Percent 
Gender/sex     
0 Male 184 32.5 
1 Female 381 67.3 
Missing 1 0.2 
Are you of Hispanic origin?     
0 Not Hispanic 545 96.3 
1 Hispanic 10 1.8 
Missing 11 1.9 
Race     
0 African American 566 100.0 
Marital status     
0 Never Married 208 36.7 
 Table continues 
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  Frequency Percent 
1 Married 135 23.9 
2 Divorced 88 15.5 
3 Separated 77 13.6 
4 Widowed 50 8.8 
Missing 8 1.4 
Education: Highest degree or level of school completed     
0 None 4 0.7 
1 Grades 8 21 3.7 
2 Grades 9 154 27.2 
3 High School 182 32.2 
4 Technical School 13 2.3 
5 Some College 120 21.2 
6 Associates 15 2.7 
7 Bachelors 34 6.0 
8 Graduate School, Masters or Above 16 2.9 
Missing 7 1.2 
Employment     
0 No 355 62.7 
1 Yes 193 34.1 
Missing 18 3.3 
Insurance: Do you have Private insurance such as Blue 
Cross, Aetna, 1199 Fund, etc.? 
  
0 No 258 45.6 
1 Yes 78 13.8 
Missing 230 40.6 
Insurance: Medicare     
0 No 258 45.6 
1 Yes 77 13.6 
Missing 231 40.8 
Insurance: Medicaid     
0 No 116 20.5 
1 Yes 341 60.2 
Missing 109 19.3 
Insurance: HMO     
0 No 245 44.3 
 Table continues 
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  Frequency Percent 
1 Yes 100 17.7 
Missing 215      38.0 
Insurance: Military or Veteran's Administration 
sponsored 
    
0 No 300 53.0 
1 Yes 3 0.5 
Missing 263 46.5 
Insurance: No insurance?     
0 No 276 48.8 
1 Yes 41 7.2 
Missing 249 44.0 
Income Level   
0 Low income 491 86.8 
1 High income 58 10.3 
Missing 17          3.0 
 
Adherence to Prescribed Medication 
 As previously stated, the dependent variable was adherence to prescribed 
medication among hypertensive African American. I measured adherence to prescribed 
medication using the MMAS instrument. Adherence to prescribed medication was 
measured at three time periods: at baseline (i.e., starting period of data collection), at 
Time 3 (i.e., after 12 months), and at Time 5 (i.e., after 24 months follow-up). Tables 3 
and 4 display the adherence to prescribed medication among hypertensive African 
Americans. At baseline, the mean total score in the MMAS was 3.62 (SD = 1.46), 
wherein less than half, or 219 (38.7%) of the 566 samples, of hypertensive African 
Americans adhered to prescribed medication at the baseline period. At Time 3, the mean 
total score in the MMAS was 3.19 (SD = 1.74), wherein less than half, or 147 (26%) out 
of the 566 samples, of hypertensive African Americans adhered to prescribed medication. 
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At Time 5, the mean total score in the MMAS was 3.85 (SD = 1.39), wherein less than 
half, or 188 (33.2%) out of the 566 samples, of hypertensive African Americans adhered 
to prescribed medication at the Time 5 period. As a comparison, the samples of 
hypertensive African American samples had the highest frequency of adherence to 
prescribed medication at baseline and had the least frequency of adherence to prescribed 
medication at Time 3 or at period after 12 months. 
Table 3 
 
Frequency and Percentage Summaries of Adherence to Prescribed Medication Among 
Hypertensive African Americans at Baseline, Time 3, and Time 5 
  Frequency Percent 
Morisky medication adherence, at baseline   
0 Nonadherent 339 59.9 
1 Adherent 219 38.7 
Missing 8      1.4 
Morisky medication adherence, at Time 3 (12 months)     
0 Nonadherent 286 50.5 
1 Adherent 147 26.0 
Missing            133     23.5 
Morisky medication adherence, at Time 5 (24 months)     
0 Nonadherent 215 38.0 
1 Adherent 188 33.2 
















Descriptive Statistics Summaries of Total Scores of Morisky Medication Among 
Hypertensive African Americans at Baseline, Time 3, and Time 5 
 N Minimum Maximum M SD 
Morisky medication 
adherence, at baseline 
(total score) 
558 0 5 3.62 1.46 
Morisky medication 
adherence, at Time 3 (total 
score) 
433 0 5 3.19 1.74 
Morisky medication 
adherence, at Time 5 (total 
score) 
403 0 5 3.85 1.39 
 
Patient-Provider Communication 
One of the independent variables was patient-provider communication. I 
measured patient-provider communication using the Physician Communication Style 
Survey. Table 5 presents the patient-provider communication scores among hypertensive 
African Americans. The mean score for patient-provider communication of the 566 
samples of hypertensive African Americans was 2.198 (SD = 0.75). The mean score was 
at the average levels, which indicated that the hypertensive African American reported an 
average quality of communication with their physicians. 
Table 5 
 
Descriptive Statistics Summaries of Total Scores of Patient-Provider Communication 
 N Minimum Maximum Mean Std. Dev. 
Patient-Provider 
communication 
502 0 3 2.18 0.75 
 
Social Support 
Another independent variable was the social support that the hypertensive African 
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Americans have received. I measured social support was measured using the MOS-SS. 
The MOS-SS has five different measures, including the overall support index and the 
four domain scores of emotional support, tangible support, affect, and positive 
interaction. Social support was also measured at three time periods: at baseline, at Time 
3, and at Time 5. Table 6 indicates the social support among hypertensive African 
Americans.  
For the overall support index, the hypertensive African American sample 
participants had the highest overall support index at Time 5 (M = 3.90, SD = 0.92) and 
had the lowest overall support index at baseline (M = 3.75, SD = 0.96). For the domain of 
emotional support, the participants had the highest emotional support at Time 5 (M = 
3.88, SD = 0.97) and had the lowest emotional support at baseline (M = 3.70, SD = 1.03). 
For the domain of tangible support, the participants had the highest tangible support at 
Time 5 (M = 3.84, SD = 1.13) and had the lowest tangible support at baseline (M = 3.65, 
SD = 1.23). For the domain of affection, the participants had the highest affection at Time 
5 (M = 4.07, SD = 1.09) and had the lowest affection at Time 3 (M = 4.00, SD = 1.12). 
For the domain of positive interaction, the participants had the highest affection at Time 5 
(M = 3.89, SD = 1.09) and had the lowest affection at baseline (M = 3.76, SD = 1.10). 
This indicated that the participants had the highest social support at Time 5, which is the 





Descriptive Statistics Summaries of Scores of Overall Support Index and Domain Scores 
of Emotional Support, Tangible Support, Affection, and Positive Interaction Among 
Hypertensive African Americans at Baseline, Time 3, and Time 5 
Period Measure N Min. Max. M SD 
Baseline Overall support index 493 1 5 3.75 0.96 
 Emotional support 493 1 5 3.70 1.03 
 Tangible support 493 1 5 3.65 1.23 
 Affection 493 1 5 4.02 1.12 
 Positive interaction 493 1 5 3.76 1.10 
Time 3 Overall support index 363 1 5 3.79 0.93 
 Emotional support 363 1 5 3.77 0.98 
 Tangible support 363 1 5 3.67 1.17 
 Affection 362 1 5 4.00 1.12 
 Positive interaction 362 1 5 3.80 1.12 
Time 5 Overall support index 406 1.05 5 3.90 0.92 
 Emotional support 406 1 5 3.88 0.97 
 Tangible support 406 1 5 3.84 1.13 
 Affection 406 1 5 4.07 1.09 
  Positive interaction 405 1 5 3.89 1.09 
 
Results  
Hierarchical logistic regression analysis was conducted to address Research 
Question 1 and examine the association of social support and patient-provider 
communication towards medication adherence for both hypertensive African American 
men and women between the ages of 21–65 years in the United States, while controlling 
for the potential confounding effect of age, gender, marital status, education, 
employment, income, and insurance. Hierarchical logistic regression analysis was also 
conducted to determine whether there is a significant difference in the relationship 
between social support and patient-provider communication and adherence by age and 
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gender among hypertensive African Americans to address Research Questions 2 and 3, 
respectively. The data used for the dependent variable of medication adherence and the 
independent variable of social support were the data at Time 3, which is the period after 
12 months follow-up from the baseline, were used in the hierarchical logistic regression 
analysis in order to determine if there was a significant difference in adherence. Although 
there were three time periods, analysis for period of Time 3 was selected to reduce the 
possibility of significant redundancy of results. A level of significance of 0.05 was used 
in the hierarchical logistic regression analysis. I concluded that there is a significant 
predictive relationship and difference in adherence to medication if the p value of the  
test is less than or equal to the level of significance value. Binomial logistic regression 
analysis is conducted to address the three research questions since the dependent variable 
in each of the different research questions which was adherence to medication is a binary 
variable (Nonadherent versus Adherent). A binomial logistic regression predicts the 
probability that an observation falls into one of two categories of a dichotomous 
dependent variable based on one or more independent variables that can be either 
continuous or categorical. In addition, a hierarchical form of the logistic regression was 
used in order to controlling for the potential confounding effect of age, gender, marital 
status, education, employment, income, and insurance in all logistic regression models 
created. 
Results of Hierarchical Logistic Regression Analysis for Research Question 1 
Hierarchical logistic regression analysis was conducted to examine the association 
of social support and patient-provider communication towards medication adherence. I 
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performed this analysis while controlling for the potential confounding effect of age, 
gender, marital status, education, employment, income, and insurance. The results of the 
hierarchical logistic regression are shown in Table 8. 
The results of the Hosmer-Lemeshow test showed that the model fit of 
hierarchical logistic regression was insignificant ( (8) = 2.71, p = 0.95), which 
indicated that the regression model for Model 2—which is the regression model in 
determining the predictive relationship of social support and patient-provider 
communication with medication adherence controlling for the potential confounding 
effect of age, gender, marital status, education, employment, income, and insurance—had 
an acceptable model fit. With the Hosmer-Lemeshow test, if p > 0.05, then the model has 
an acceptable fit. This means that the predictive relationship of social support and patient-
provider communication with medication adherence after controlling for the potential 
confounding effect of age, gender, marital status, education, employment, income, and 
insurance was insignificant. The Cox and Snell R2, or measure of effect size, of Model 2 
of the hierarchical logistic regression model was 0.15, which indicated a low effect size, 
meaning that both the independent variables of social support and patient-provider 
communication explained a variance of only 15% to predict medication adherence after 
controlling for age, gender, marital status, education, employment, income, and 
insurance.  
On the other hand, the Nagelkerke R2 of Model 2 of the hierarchical logistic 
regression model was 0.20, which also indicated a low effect size, meaning that both the 
independent variables of social support and patient-provider communication explained a 
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variance of only 20% to predict medication adherence after controlling for age, gender, 
marital status, education, employment, income, and insurance. Table 7 illustrates the 
results of the classification table, which indicated that there was 82.4% of hypertensive 
African American samples that were nonadherent to the prescribed medication that were 
correctly predicted and there were 45.1% of hypertensive African American samples that 
were adherent to the prescribed medication. The overall accuracy of the prediction of the 
medication adherence was 67.1%. 
My investigation of the individual predictive relationship in the hierarchical 
logistic regression model in Table 8 showed that only the patient-provider 
communication (Wald (1) = 4.43, p = 0.04) was significantly associated or have a 
significant predictive relationship with medication adherence after controlling for the 
potential confounding effect of age, gender, marital status, education, employment, 
income, and insurance. There was a significant predictive relationship because the p 
value was less than the level of significance value of 0.05. The examination of the 
coefficient of the odd ratio statistic of Exp(β) showed that the odds ratio of patient-
provider communication was 1.72, which implied that a one-unit increase in patient-
provider communication score increased the odds of the hypertensive African Americans 
to adhere to prescribed medication—versus not adhering to prescribed medication—by 
0.72 or 72%.  
In contrast, the overall support index (Wald (1) = 1.05, p = 0.31) was not 
significantly associated or have significant predictive relationships with medication 
adherence after controlling for the potential confounding effect of age, gender, marital 
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status, education, employment, income, and insurance. With these results of the 
hierarchical logistic regression analysis, the first null hypothesis—which states that there 
is no significant difference in adherence to medication between individuals with and 
without social support and patient-provider communication—was rejected. The 
alternative hypothesis—which states that there is a significant difference in adherence to 
medication between individuals with and without social support and patient-provider 
communication—was supported. A significant association was observed only between 
patient-provider communication and medication adherence. 
Table 7 
 
Classification Table of Hierarchical Logistic Regression Model for Adherence to 
Prescribed Medication Among Hypertensive African Americans 
 Observed Predicted 
 
Morisky medication 







 Morisky medication 
adherence, at Time 3 
(dichotomized) 
Nonadherent 84 18 82.4 
Adherent 39 32 45.1 








Hierarchical Logistic Regression Results of Association of Social Support and Patient-
Provider Communication with Adherence to Prescribed Medication Among Hypertensive 
African Americans Controlling for Age, Gender, Marital Status, Education, Employment, 
Income, and Insurance  
Block Variables B S.E. Wald df p Exp (B) 
1 Sex (Female) -0.72 0.40 3.26 1 0.07 0.49 
Age 0.06 0.02 6.12 1 0.01 1.06 
Marital status (Never Married): 
Reference Category   1.85 4 0.76  
Marital status (Married) -0.07 0.67 0.01 1 0.91 0.93 
Marital status (Divorced) -0.06 0.72 0.01 1 0.94 0.94 
Marital status (Separated) -0.63 0.76 0.69 1 0.41 0.53 
Marital status (Widowed) -0.56 0.78 0.52 1 0.47 0.57 
Education (None): Reference 
Category   3.92 8 0.86  
Education (Grades 8) -20.27 28167.94 0.00 1 1.00 0.00 
Education (Grades 9) -0.29 1.09 0.07 1 0.79 0.75 
Education (High School) -0.65 0.96 0.45 1 0.50 0.52 
Education (Technical School) -0.18 0.95 0.03 1 0.85 0.84 
Education (Some College) -0.18 1.35 0.02 1 0.90 0.84 
Education (Associates) 0.26 0.96 0.07 1 0.79 1.30 
Education (Bachelors) -1.00 1.66 0.36 1 0.55 0.37 
Education (Graduate School, 
Masters or above) 0.48 1.08 0.19 1 0.66 1.61 
Employment (Yes) 0.18 0.48 0.14 1 0.71 1.20 
Insurance: Private Insurance 
(Yes) 0.59 0.65 0.83 1 0.36 1.80 
Insurance: Medicare (Yes) 0.19 0.56 0.12 1 0.73 1.21 
Insurance: Medicaid (Yes) 0.53 0.52 1.05 1 0.31 1.71 
Insurance: HMO (Yes) 0.34 0.46 0.57 1 0.45 1.41 
Insurance: No insurance? (Yes) -0.63 0.81 0.60 1 0.44 0.54 
Income -0.06 0.20 0.10 1 0.75 0.94 
Constant -3.37 2.54 1.76 1 0.18 0.03 
       
2 Sex (Female) -0.64 0.41 2.49 1 0.12 0.53 
Age 0.06 0.02 5.26 1 0.02 1.06 
Marital status (Never Married): 
Reference Category   2.01 4 0.73  
    Table continues 
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Block Variables B S.E. Wald df p Exp (B) 
Marital status (Married) -0.14 0.70 0.04 1 0.84 0.87 
Marital status (Divorced) -0.20 0.75 0.07 1 0.79 0.82 
Marital status (Separated) -0.80 0.80 1.01 1 0.32 0.45 
Marital status (Widowed) -0.59 0.81 0.53 1 0.47 0.56 
Education (None): Reference 
Category   5.04 8 0.75  
Education (Grades 8) -21.12 28397.57 0.00 1 1.00 0.00 
Education (Grades 9) -0.83 1.16 0.51 1 0.48 0.44 
Education (High School) -1.10 1.03 1.15 1 0.29 0.33 
Education (Technical School) -0.70 1.02 0.47 1 0.49 0.50 
Education (Some College) -0.55 1.43 0.15 1 0.70 0.58 
Education (Associates) -0.14 1.02 0.02 1 0.89 0.87 
Education (Bachelors) -1.74 1.70 1.06 1 0.30 0.18 
Education (Graduate School, 
Masters or above) 0.19 1.13 0.03 1 0.87 1.21 
Employment (Yes) 0.21 0.49 0.19 1 0.66 1.24 
Insurance: Private Insurance 
(Yes) 0.75 0.66 1.29 1 0.26 2.11 
Insurance: Medicare (Yes) 0.25 0.58 0.18 1 0.67 1.28 
Insurance: Medicaid (Yes) 0.56 0.54 1.08 1 0.30 1.76 
Insurance: HMO (Yes) 0.18 0.49 0.13 1 0.72 1.19 
Insurance: No insurance? Yes) -0.81 0.85 0.93 1 0.34 0.44 
Income -0.05 0.21 0.05 1 0.82 0.96 
Patient-Provider communication 0.54 0.26 4.43 1 0.04 1.72 
Overall support index at Time 3  0.21 0.20 1.05 1 0.31 1.23 
Constant -4.62 2.63 3.08 1 0.08 0.01 
Note. Hosmer-Lemeshow X2(8) = 2.71, p = 0.95, Cox & Snell R2 = 0.15, Nagelkerke R2 = 0.20, 
N = 173 
Results of Hierarchical Logistic Regression Analysis for Research Question 2  
Hierarchical logistic regression analysis was also conducted to examine the 
association of social support and patient-provider communication with medication 
adherence by age among hypertensive African Americans controlling for the potential 
confounding effect of gender, marital status, education, employment, income, and 
insurance. The hierarchical logistic regression analysis was conducted to determine 
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whether there is a significant difference in the relationship between social support and 
patient-provider communication and adherence by age among hypertensive African 
Americans. I investigated the significance of the interaction effects of social support and 
age, as well as of patient-provider communication and age, on medication adherence. The 
results of the hierarchical logistic regression with age are shown in Table 10. 
The results of the Hosmer-Lemeshow test showed that the model fit of 
hierarchical logistic regression was insignificant (χ2(8) = 6.43, p = 0.60), which indicated 
that the regression model for Model 2—which is the regression model in determining the 
association of social support and patient-provider communication with medication 
adherence by age controlling for the potential confounding effect of gender, marital 
status, education, employment, income, and insurance—had an acceptable model fit. This 
means that the association of social support and patient-provider communication with 
medication adherence by age among hypertensive African Americans after controlling for 
the potential confounding effect of gender, marital status, education, employment, 
income, and insurance was insignificant. The Cox and Snell R2, or measure of effect size, 
of Model 2 of the hierarchical logistic regression model was 0.16, which indicated a low 
effect size, meaning that individual effects of the independent variables of social support, 
patient-provider communication, and age; and the interaction effects of overall social 
support and age; and patient-provider communication and age explained a variance of 
only 16% to predict medication adherence after controlling for gender, marital status, 
education, employment, income, and insurance.  
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On the other hand, the Nagelkerke R2 of Model 2 of the hierarchical logistic 
regression model was 0.22, which also indicated a low effect size, meaning that the 
individual effects of the independent variables of social support, patient-provider 
communication, and age; and the interaction effects of overall social support and age; and 
patient-provider communication and age explained a variance of only 22% to predict 
medication adherence after controlling for gender, marital status, education, employment, 
income, and insurance. Table 9 showed the results of the classification table, which 
indicated that there was 76.5% of hypertensive African American samples that were 
nonadherent to the prescribed medication that were correctly predicted and there were 
45.1% of hypertensive African American samples that were adherent to the prescribed 
medication when considering the interaction effect of age. The overall accuracy of the 
prediction of the medication adherence was 63.6% when considering the interaction 
effect of age. 
My investigation of the individual predictive relationship in the hierarchical 
logistic regression model in Table 11 showed the individual effects of overall support 
index (Wald(1) = 2.27, p = 0.13), patient-provider communication (Wald(1) = 0.00, p = 
0.95), and age (Wald(1) = 1.88, p = 0.17) were not significantly associated or do not have 
a significant predictive relationship with medication adherence after controlling for the 
potential confounding effect of gender, marital status, education, employment, income, 
and insurance. The results of the hierarchical logistic regression showed that medication 
adherence was not significantly different by the individual differences of age among 
hypertensive African Americans. Also, the interaction effects of overall social support 
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and age (Wald(1) = 1.87, p = 0.17) and patient-provider communication and age (Wald(1) 
= 0.14, p = 0.71) on medication adherence after controlling for the potential confounding 
effect of gender, marital status, education, employment, income, and insurance were 
insignificant. This means that there is no significant difference in the relationship 
between social support and patient-provider communication and medication adherence by 
age among hypertensive African Americans. The results were insignificant because the p 
values were all greater than the level of significance value. With these results of the 
hierarchical logistic regression analysis, the second null hypothesis—which states that 
there is no significant difference in the relationship between social support and patient-
provider communication and adherence by age among hypertensive African Americans—
was not rejected.  
Table 9 
 
Classification Table of Hierarchical Logistic Regression Model for Adherence to 
Prescribed Medication Among Hypertensive African Americans Considering Interaction 
Effect of Age 
 Observed Predicted 
 
Morisky medication 







 Morisky medication 
adherence, at Time 3 
(dichotomized) 
Nonadherent 78 24 76.5 
Adherent 39 32 45.1 







Hierarchical Logistic Regression Results of Individual Association and Interaction 
Effects of Social Support, Patient-Provider Communication, and Age with Adherence to 
Prescribed Medication Among Hypertensive African Americans Controlling for Gender, 
Marital Status, Education, Employment, Income, and Insurance 
Block 
Variables B S.E. Wald 
D
f 
p Exp (B) 
1 Sex (Female) -0.61 0.39 2.55 1 0.11 0.54 
Marital status (Never Married): 
Reference Category   1.18 4 0.88  
Marital status (Married) -0.30 0.65 0.22 1 0.64 0.74 
Marital status (Divorced) -0.26 0.70 0.13 1 0.72 0.78 
Marital status (Separated) -0.59 0.75 0.63 1 0.43 0.55 
Marital status (Widowed) -0.67 0.77 0.76 1 0.38 0.51 
Education (None): Reference 
Category   3.65 8 0.89  
Education (Grades 8) -21.35 28280.87 0.00 1 1.00 0.00 
Education (Grades 9) -0.28 1.08 0.07 1 0.79 0.75 
Education (High School) -0.98 0.94 1.09 1 0.30 0.38 
Education (Technical School) -0.58 0.92 0.39 1 0.53 0.56 
Education (Some College) -0.64 1.30 0.24 1 0.62 0.53 
Education (Associates) -0.23 0.92 0.06 1 0.80 0.79 
Education (Bachelors) -1.28 1.61 0.63 1 0.43 0.28 
Education (Graduate School, 
Masters or above) 0.03 1.05 0.00 1 0.98 1.03 
Employment (Yes) 0.19 0.46 0.17 1 0.68 1.21 
Insurance: Private Insurance 
(Yes) 0.58 0.63 0.84 1 0.36 1.78 
Insurance: Medicare (Yes) -0.10 0.54 0.03 1 0.86 0.91 
Insurance: Medicaid (Yes) 0.55 0.51 1.18 1 0.28 1.74 
Insurance: HMO (Yes) 0.33 0.45 0.55 1 0.46 1.39 
Insurance: No insurance? (Yes) -0.68 0.80 0.73 1 0.39 0.51 
Income -0.07 0.19 0.13 1 0.72 0.93 
Constant 0.47 1.95 0.06 1 0.81 1.60 
2 Sex (Female) -0.65 0.41 2.47 1 0.12 0.52 
Marital status (Never Married): 
Reference Category   1.91 4 0.75  
Marital status (Married) -0.15 0.70 0.05 1 0.83 0.86 
Marital status (Divorced) -0.20 0.75 0.07 1 0.79 0.82 
Marital status (Separated) -0.82 0.79 1.07 1 0.30 0.44 




Variables B S.E. Wald 
D
f 
p Exp (B) 
Marital status (Widowed) -0.51 0.81 0.39 1 0.53 0.60 
Education (None): Reference 
Category   5.12 8 0.75  
Education (Grades 8) -21.59 28196.26 0.00 1 1.00 0.00 
Education (Grades 9) -1.04 1.20 0.75 1 0.39 0.36 
Education (High School) -1.31 1.07 1.49 1 0.22 0.27 
Education (Technical School) -0.89 1.06 0.70 1 0.40 0.41 
Education (Some College) -0.80 1.46 0.30 1 0.58 0.45 
Education (Associates) -0.37 1.06 0.12 1 0.73 0.69 
Education (Bachelors) -1.96 1.70 1.33 1 0.25 0.14 
Education (Graduate School, 
Masters or above) -0.03 1.16 0.00 1 0.98 0.97 
Employment (Yes) 0.24 0.49 0.23 1 0.63 1.27 
Insurance: Private Insurance 
(Yes) 0.86 0.67 1.68 1 0.20 2.37 
Insurance: Medicare (Yes) 0.39 0.59 0.44 1 0.51 1.48 
Insurance: Medicaid (Yes) 0.71 0.56 1.61 1 0.21 2.04 
Insurance: HMO (Yes) 0.21 0.50 0.18 1 0.68 1.23 
Insurance: No insurance? (Yes) -0.73 0.87 0.70 1 0.40 0.48 
Income -0.05 0.21 0.05 1 0.82 0.95 
Patient-Provider communication -0.12 1.83 0.00 1 0.95 0.89 
Overall support index at Time 3  1.92 1.27 2.27 1 0.13 6.80 
Age 0.15 0.11 1.88 1 0.17 1.16 
Patient-Provider communication * 
Age Category 0.01 0.03 0.14 1 0.71 1.01 
Overall support index at Time 3 * 
Age Category -0.03 0.02 1.87 1 0.17 0.97 
Constant -9.98 6.47 2.38 1 0.12 0.00 
Note. Hosmer-Lemeshow X2(8) = 6.43, p = 0.60, Cox & Snell R2 = 0.16, Nagelkerke R2 = 0.22, 
N = 173  
Results of Hierarchical Logistic Regression Analysis for Research Question 3 
Hierarchical logistic regression analysis was also conducted to examine the 
association of social support and patient-provider communication with medication 
adherence by gender among hypertensive African Americans controlling for the potential 
confounding effect of age, marital status, education, employment, income, and insurance. 
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The hierarchical logistic regression analysis was conducted to determine whether there is 
a significant difference in the relationship between social support and patient-provider 
communication and adherence by gender among hypertensive African Americans. I 
investigated the significance of the interaction effects of social support and gender; and 
patient-provider communication and gender on medication adherence. The results of the 
hierarchical logistic regression with gender are shown in Table 12. 
The results of the Hosmer-Lemeshow test showed that the model fit of 
hierarchical logistic regression was insignificant (χ2(8) = 8.31, p = 0.40), which indicated 
that the regression model for Model 2—which is the regression model in determining the 
association of social support and patient-provider communication with medication 
adherence by gender controlling for the potential confounding effect of age, marital 
status, education, employment, income, and insurance—had an acceptable model fit. This 
means that the association of social support and patient-provider communication with 
medication adherence by gender among hypertensive African Americans after controlling 
for the potential confounding effect of age, marital status, education, employment, 
income, and insurance was insignificant. The Cox and Snell R2, or measure of effect size, 
of Model 2 of the hierarchical logistic regression model was 0.15, which indicated a low 
effect size, meaning that individual effects of the independent variables of social support, 
patient-provider communication, and gender; and the interaction effects of overall social 
support and gender; and patient-provider communication and gender explained a variance 
of only 15% to predict medication adherence after controlling for age, marital status, 
education, employment, income, and insurance.  
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On the other hand, the Nagelkerke R2 of Model 2 of the hierarchical logistic 
regression model was 0.20, which also indicated a low effect size, meaning that the 
individual effects of the independent variables of social support, patient-provider 
communication, and gender; and the interaction effects of overall social support and 
gender; and patient-provider communication and gender explained a variance of only 
20% to predict medication adherence after controlling for age, marital status, education, 
employment, income, and insurance. Table 11 showed the results of the classification 
table, which indicated that there was 81.4% of hypertensive African American samples 
that were nonadherent to the prescribed medication that were correctly predicted and 
there were 46.5% of hypertensive African American samples that were adherent to the 
prescribed medication when considering the interaction effect of gender. The overall 
accuracy of the prediction of the medication adherence was 67.1% when considering the 
interaction effect of gender. 
My investigation of the individual predictive relationship in the hierarchical 
logistic regression model in Table 12 showed the individual effects of overall support 
index (Wald(1) = 0.89, p = 0.35), patient-provider communication (Wald(1) = 0.75, p = 
0.39), and gender (Wald(1) = 0.30, p = 0.58) were not significantly associated or do not 
have a significant predictive relationship with medication adherence after controlling for 
the potential confounding effect of age, marital status, education, employment, income, 
and insurance. The results of the hierarchical logistic regression showed that medication 
adherence was not significantly different by the individual differences of gender among 
hypertensive African Americans. Also, the interaction effects of overall social support 
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and gender (Wald (1) = 0.23, p = 0.63) and patient-provider communication and gender 
(Wald(1) = 0.10, p = 0.75) on medication adherence after controlling for the potential 
confounding effect of age, marital status, education, employment, income, and insurance 
were insignificant. This means that there is no significant difference in the relationship 
between social support and patient-provider communication and medication adherence by 
gender among hypertensive African Americans. The results were insignificant because 
the p values were all greater than the level of significance value. With these results of the 
hierarchical logistic regression analysis, the third null hypothesis—which states that there 
is no significant difference in the relationship between social support and patient-provider 
communication and adherence between hypertensive African American men and 
women—was not rejected. 
Table 11 
 
Classification Table of Hierarchical Logistic Regression Model for Adherence to 
Prescribed Medication Among Hypertensive African Americans Considering Interaction 
Effect of Gender 
 Observed Predicted 
 
Morisky medication 







 Morisky medication 
adherence, at Time 3 
(dichotomized) 
Nonadherent 83 19 81.4 
Adherent 38 33 46.5 







Hierarchical Logistic Regression Results of Individual Association and Interaction 
Effects of Social Support, Patient-Provider Communication, and Gender with Adherence 
to Prescribed Medication Among Hypertensive African Americans Controlling for Age, 
Marital Status, Education, Employment, Income, and Insurance 
 
Block 








1 Age 0.05 0.02 5.42 1 0.02 1.06 
Marital status (Never Married): 
Reference Category   1.73 4 0.79  
Marital status (Married) -0.20 0.65 0.09 1 0.76 0.82 
Marital status (Divorced) -0.30 0.70 0.19 1 0.67 0.74 
Marital status (Separated) -0.72 0.74 0.94 1 0.33 0.49 
Marital status (Widowed) -0.66 0.76 0.75 1 0.39 0.52 
Education (None): Reference Category   3.22 8 0.92  





61 0.00 1 1.00 0.00 
Education (Grades 9) -0.25 1.10 0.05 1 0.82 0.78 
Education (High School) -0.55 0.97 0.33 1 0.57 0.58 
Education (Technical School) -0.02 0.95 0.00 1 0.98 0.98 
Education (Some College) 0.02 1.33 0.00 1 0.99 1.02 
Education (Associates) 0.25 0.96 0.07 1 0.79 1.29 
Education (Bachelors) -0.74 1.64 0.21 1 0.65 0.48 
Education (Graduate School, Masters or 
above) 0.45 1.09 0.17 1 0.68 1.57 
Employment (Yes) 0.24 0.47 0.26 1 0.61 1.27 
Insurance: Private Insurance (Yes) 0.52 0.63 0.68 1 0.41 1.68 
Insurance: Medicare (Yes) 0.26 0.55 0.22 1 0.64 1.29 
Insurance: Medicaid (Yes) 0.59 0.51 1.34 1 0.25 1.81 
Insurance: HMO (Yes) 0.27 0.45 0.36 1 0.55 1.31 
Insurance: No insurance? (Yes) -0.70 0.81 0.75 1 0.39 0.50 
Income -0.04 0.20 0.04 1 0.85 0.96 
Constant -3.27 2.51 1.70 1 0.19 0.04 
2 Age 0.06 0.02 5.20 1 0.02 1.06 
Marital status (Never Married): 
Reference Category   1.94 4 0.75  
Marital status (Married) -0.16 0.70 0.05 1 0.82 0.85 
Marital status (Divorced) -0.20 0.75 0.07 1 0.79 0.82 












Marital status (Separated) -0.79 0.80 0.98 1 0.32 0.45 
Marital status (Widowed) -0.62 0.81 0.59 1 0.44 0.54 
Education (None): Reference Category   5.13 8 0.74  





48 0.00 1 1.00 0.00 
Education (Grades 9) -0.80 1.17 0.47 1 0.50 0.45 
Education (High School) -1.05 1.06 0.98 1 0.32 0.35 
Education (Technical School) -0.63 1.04 0.37 1 0.54 0.53 
Education (Some College) -0.47 1.44 0.11 1 0.74 0.62 
Education (Associates) -0.02 1.05 0.00 1 0.98 0.98 
Education (Bachelors) -1.61 1.71 0.88 1 0.35 0.20 
Education (Graduate School, Masters or 
above) 0.28 1.15 0.06 1 0.81 1.32 
Employment (Yes) 0.21 0.49 0.19 1 0.66 1.24 
Insurance: Private Insurance (Yes) 0.73 0.67 1.20 1 0.27 2.07 
Insurance: Medicare (Yes) 0.20 0.59 0.12 1 0.73 1.23 
Insurance: Medicaid (Yes) 0.55 0.55 1.03 1 0.31 1.74 
Insurance: HMO (Yes) 0.15 0.49 0.09 1 0.76 1.16 
Insurance: No insurance? (Yes) -0.82 0.85 0.94 1 0.33 0.44 
Income -0.05 0.21 0.05 1 0.82 0.96 
Patient-Provider communication 0.41 0.48 0.75 1 0.39 1.51 
Overall support index at Time 3  0.37 0.39 0.89 1 0.35 1.44 
Gender -1.05 1.91 0.30 1 0.58 0.35 
Patient-Provider communication * 
Gender Category 0.18 0.56 0.10 1 0.75 1.20 
Overall support index at Time 3 * 
Gender Category -0.22 0.45 0.23 1 0.63 0.80 
Constant -4.49 2.73 2.71 1 0.10 0.01 
Note. Hosmer-Lemeshow X2(8) = 8.31, p = 0.40, Cox & Snell R2 = 0.15, Nagelkerke R2 = 0.20, 
N = 173  
 
Summary 
The purpose of this quantitative cross-sectional study was to examine the 
association of social support and patient-provider communication towards medication 
adherence for both hypertensive African American men and women between the ages of 
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21–65 years in the United States. Descriptive statistics analysis and hierarchical logistic 
regression analysis were conducted to test the research questions and hypotheses posed in 
this study. The results of the hierarchical logistic regression analysis for Research 
Question 1 showed that the patient-provider communication was significantly associated 
or have a significant predictive relationship with medication adherence of hypertensive 
African Americans after controlling for the potential confounding effect of age, gender, 
marital status, education, employment, income, and insurance. Specifically, a higher 
quality of patient-provider communication score would results to a higher odds or 
probability of the hypertensive African Americans to adhere to prescribed medication 
versus not adhering to prescribed medication. The results of the hierarchical logistic 
regression analysis for Research Question 2 showed that there is no significant difference 
in the relationship between social support and patient-provider communication and 
adherence by age among hypertensive African Americans after controlling for the 
potential confounding effect of gender, marital status, education, employment, income, 
and insurance. The results of the hierarchical logistic regression analysis for Research 
Question 3 showed that there is no significant difference in the relationship between 
social support and patient-provider communication and adherence between hypertensive 
African American men and women after controlling for the potential confounding effect 
of age, marital status, education, employment, income, and insurance. In Section 4, I will 
review the findings from the study, explain how they relate to the literature on this topic, 





Section 4: Application to Professional Practice and Implications for Social Change  
Introduction 
Previous researchers have demonstrated the importance of medication adherence 
of hypertensive patients for health improvement (Hill et al., 2011; Zullig et al., 2013). 
The literature on the relationship of social support and patient-provider communication 
and medication adherence among African Americans with hypertension, however, is still 
lacking (Cornwell & Waite, 2012; Lewis et al., 2012). Therefore, the purpose of this 
quantitative cross-sectional study was to investigate the association between social 
support and patient-provider communication towards medication adherence for both 
hypertensive African American men and women between the ages of 21 and 65 years in 
the United States. In this study, I used social support and patient-provider communication 
as the independent variables, while adherence to high blood pressure was the dependent 
variable.  
I used descriptive and hierarchal logistic regression model analyses to analyze 
data from a total of 566 hypertensive African Americans. The first independent variable 
was social support, which I defined as support perceived or received from family, friends, 
health providers, faith and community organizations, and social networking groups or 
programs that specifically help hypertensive individuals. The second independent 
variable was patient-provider communication, which was defined as the patients’ 
perception of the provider and clarity of advice given to them. The dependent variable 
was adherence to high blood pressure medication, which I defined as how well and 
consistently a patient follows recommended treatment and the plan developed by his or 
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her healthcare provider. The control variables were gender, age, income, education, 
employment, insurance status, and place of residence. The length of time in treatment, 
number of medications, and the severity of hypertension were also used as control 
variables. The following research questions and hypotheses were used to guide the study: 
Research Question 1: Are social support and patient-provider communication 
associated with hypertensive African Americans self-reported medication 
adherence?  
H01: There is no significant difference in adherence to medication between 
individuals with and without social support and patient-provider 
communication.  
H11: There is a significant difference in adherence to medication between 
individuals with and without social support and patient-provider 
communication.  
Research Question 2: What is the association between social support and patient-
provider communication by age among hypertensive African Americans? 
H02: There is no significant difference in the relationship between social 
support and patient-provider communication and adherence by age among 
hypertensive African Americans. 
H12: There is a significant difference in the relationship between social 
support and patient-provider communication and adherence by age among 
hypertensive African Americans. 
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Research Question 3: What is the association between social support and patient-
provider communication among hypertensive African American men and women? 
H03: There is no significant difference in adherence to medication between 
hypertensive African American men and women with or without patient-
provider communication and social support.  
H13: There is a significant difference in adherence to medication between 
hypertensive African American men and women with or without patient-
provider communication and social support. 
The results of the analyses showed that among the three research questions, only 
Research Question 1 indicated significant results. In particular, I found that patient-
provider communication is a positive and significant predictor of medication adherence 
of African Americans with hypertension. Social support, however, was not found to 
significantly predict medication adherence. There was also no significant difference in 
medication adherence based on age and gender. The results of this study revealed the 
explicit relationships between social support, patient-provider communication, and 
medication adherence in the context of African Americans with hypertension in the 
United States.  
It is especially important for researchers to understand the dynamics of patients 
and providers and the former’s commitment to improve their health. The results of this 
study provide additional context regarding factors that influence medication adherence 
and overall healthcare experiences of African Americans with hypertension. In this 
section, I will discuss the results of this study in light of the existing literature on African 
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American with hypertension and their health-seeking behaviors as well as the influence 
of social support, patient-provider communication, and other factors on medication 
adherence.  
Interpretation of Findings 
In this section, I will interpret the results based on the existing related studies on 
the role of support and patient-provider communication on medication adherence of 
African Americans with hypertension. Hypertension is a chronic disease that greatly 
affects the quality of life of individuals (Bokhour et al., 2016). Scholars have reported 
that 45% of African American men and 46% of African American women have 
hypertension, in comparison to 34% of European American men and 31% of European 
American women (CDC, 2016; Pettey et al., 2016).  
To answer the first research question, I focused on the relationship of social 
support and patient-provider communication and their association with African American 
self-reports of medication adherence. To answer the second research question, I 
determined the association between social support and patient-provider communication 
among African Americans with hypertension based on their age. To answer the third and 
last research question, I tackled the relationship between medication adherence and social 
support and patient-provider communication among hypertensive African American men 
and women.  
Social Support, Patient-Provider Communication, and Medication Adherence 
  Drawing from previous literature on the influence of both social support and 
patient-provider communication (Levinson et al., 2010; Schoenthaler et al., 2009), I 
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hypothesized that there would be a significant difference in adherence to medication 
between individuals with and without social support and patient-provider communication. 
The results of the hierarchal logistic regression analysis for Research Question 1 showed 
that only patient-provider communication had a significant predictive relationship with 
medication adherence. Social support was not found to be a significant predictor of 
medication adherence. The positive finding on patient-provider communication as a 
predictive variable of medication adherence lends further support to the conclusions of 
Levinson et al. (2010) and Schoenthaler et al. (2009), who demonstrated that the 
multidimensional role of patient-provider communication has a large impact on patients’ 
willingness to adhere to medication. The open communication between the patient and 
provider allows the former to express their thoughts and feelings about their health, 
treatment, and lifestyle choices (Braverman & Dedier, 2009). This increases the trust 
between the patient and the provider and was found to be an effective means to 
encourage patients with chronic diseases to be more responsible with regards to their 
health (Martin et al., 2011). 
 This significant predictive role of patient-provider communication on medication 
adherence among African Americans with hypertension provides further evidence on the 
lived experiences of hypertensive African Americans. In another study, Martin et al. 
(2011) concluded that lower levels of trust in health providers are also associated with 
lower patient satisfaction and treatment adherence among racial minority populations, 
including African Americans. This may be the reason why African Americans are less 
likely to seek or receive needed health services, procedures, or routine treatments for 
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hypertension in comparison to European Americans (Martin et al., 2011). The poor 
quality of relationships between patients and provider is a barrier in improving healthcare 
among ethnic minority groups. Based on the results of this study, the same could be said 
concerning the situation of African Americans with hypertension. The distrust towards 
providers has become a barrier that prevents African Americans from demonstrating 
positive health-seeking behaviors (Abel & Efird, 2013). 
On the other hand, the nonsignificant result of the relationship between social 
support and medication adherence is incongruent to the findings of Nurullah (2012), who 
showed that social support is vital in promoting better health outcomes and improving 
chronic diseases, such as hypertension. According to the TRA, attitudes can be based on 
multiple factors, including past experiences, social support, health education and literacy, 
or the environment (Glanz et al., 2015). TRA also states that individual motivational 
factors influence the likelihood of performing a specific behavior (Hackman & 
Knowlden, 2014). In this case, I hypothesized that social support could be a significant 
predictor variable of medication adherence. As such, the nonsignificant findings could be 
cleared by looking into the social support experiences of African Americans with 
hypertension or chronic diseases. Research on this topic is scarce; however, lack of social 
support is considered a large barrier on medication adherence among African Americans 
with chronic diseases (Rimando, 2013). It is possible that the types of social support used 
in the present study were not comprehensive enough in capturing the experiences of 
African Americans with hypertension. This could have also been a result of the 
methodology used in this study. In any case, the disparity between the nonsignificant 
82 
 
findings of this study on the predictor role of social support on medication adherence in 
the context of African Americans with hypertension must be investigated further. 
Medication Adherence Based on Age and Gender 
 To answer the second research question, I explored the association between social 
support and patient-provider communication by age among hypertensive African 
Americans, while in the third research question, I examined the role of gender on the 
medication adherence behaviors of African Americans with or without patient-provider 
communication and social support. I hypothesized (a) that there would be a significant 
difference between old and young African Americans with hypertension in terms of 
social support and patient-provider communication and (b) that there would be greater 
adherence to treatment for African American women compared to men with higher 
patient-provider communication and social support. These two research questions 
focused on the presence of disparity, if any, by age and gender, respectively.  
The results were nonsignificant for both research questions. Rates of uncontrolled 
hypertension were found to be higher for African American older adults (Cornwell & 
Waite, 2012). The results of Research Question 2—that medication adherence is not 
significantly different between old and young African American—proved that in terms of 
social support and patient-provider communication, the experiences of both old and 
young African Americans are similar. In fact, this result substantiated previous scholars’ 
conclusions that age does not predict or influence medication adherence for hypertension 
patients. For instance, Nair et al. (2011) posited that difference in age did not appear to be 
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a reliable measure of influence of medication adherence among young and old African 
Americans with hypertension.  
Lewis (2012) further demonstrated that several studies did not show a significant 
relationship between social support and medication adherence. This may be related to 
attitudes towards medication adherence. Patients’ beliefs and attitudes towards 
medication have been shown to be important drivers for adherence and disease outcomes 
in adults (Martin et al., 2011). The nonsignificant result in this study was incongruent to 
the results of Lewis (2012) who concluded that it is important for African American men 
to have a collaborative relationship with their healthcare provider, which also had a 
significant positive influence on their adherence to recommended medications. This 
researcher also showed that there is no association between gender and medication 
adherence (Lewis, 2012). 
In the case of African American men and women, I found that there was no 
significant difference between the social support and patient-provider communication 
between the two groups. This result was incongruent to those of Ashaye and Giles 
(2003), who demonstrated that African American women tend to have a greater 
awareness of their condition and are quicker to seek treatment, leading to better blood 
pressure control rates. In addition, Lewis et al. (2012) posited that higher rates of 
medication nonadherence existed for African American men even in environments with 
equal access to care regardless race or socioeconomic status. Despite these previous 
findings, the nonsignificant result in this study reflected the notion that there is no 
association between gender and medication adherence (see Lewis, 2012). The disparity in 
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literature on the role of gender on medication adherence must be comprehensively 
researched to provide a consensus for the benefit of researchers and practitioners. 
To summarize the interpretation of the findings, in the present study, I provided 
support to the notion that patient-provider communication is a predictive variable of 
medication adherence of African Americans with hypertension. This offers additional 
support to the vital role of trust between patient and provider, especially among 
minorities such as African Americans. This entails not only providing more opportunities 
for firsthand experiential exercises or practicum experiences, but also ensuring that the 
skills development programs deliver quality results for the providers. The nonsignificant 
result concerning the role of social support must also be studied further. In addition, I 
noted that despite the nonsignificant result, age and gender are critical aspects of 
medication adherence that must also be studied. 
Limitations of the Study 
 Despite the significant result, it is important to discuss the findings based on the 
limitations that arose throughout the research. One major theoretical limitation in 
understanding the results of the present study was the scarcity of recent research focusing 
on the relationships of social support, patient-provider communication, and medication 
adherence among African Americans with hypertension in the United States. Because of 
this, it has been challenging to draw out social psychological and cognitive processes that 
occur in this context. Instead, I was only able to identify the explicit relationships and 
differences between the independent variables. This can be attributed to the quantitative 
nature of the study. Quantitative investigators focus on numbers and analysis to draw 
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conclusions about relationships of measured variables. While one of the advantages of 
using quantitative methods in the study is that the method can manage data from a large 
number of samples, it does not provide insight on underlying theories and processes of a 
relationship. Thus, future researchers may select qualitative methods to address this 
limitation. This can also help researchers contextualize the disparities in results. 
 Another limitation can be attributed to the operationalization of variables, 
specifically the scales of measure for the independent variables of social support and 
patient-provider communication. Nominal scale was used for these independent 
variables, which could not account for other aspects such as length of experience, quality 
of experience, amount of time spent in the treatment. This could have limited insights and 
interpretation on the specific dimensions of each variable and how these can invariably 
affect the self-reported medication adherence of the participants. It is important for future 
researchers to differentiate different types of social support and various dimensions of 
patient-provider communication to further nuance the relationships among the variables. 
 The sampling method could also be a source of limitation of the study. A total of 
493 samples were removed because they did not satisfy the criteria. The use of samples 
whose age range from 21 to 65 years old could have limited the analysis in terms of data 
saturation. In addition, the use of an age range of 21 to 65 years old as a criterion could 
restricted the insights from that could be derived from the data pool. Future researchers 




To summarize, three major limitations were seen in the present study. The first 
limitation was the lack of research on the specific dimensions of these variables and how 
they could influence the willingness of African Americans with hypertension to stay 
committed to a medication. This impeded the contextualization of the results in the 
broader literature on healthcare of racial minorities. The second limitation referred to the 
methodology in which nominal scales were used for the independent variables. This 
limited the possible in-depth distinction of the influence of social support and patient-
provider communication on medication adherence. The third limitation focused more on 
the methodology, particularly the sampling method used, which could have hindered in-
depth interpretation of the results due to the removal of samples. In the next subsection, I 
will provide a set of recommendations for future research. 
Recommendations 
 Based on the findings of the study, I recommend that future researchers build 
upon the results of this study and conduct studies that analyze specific aspects of each 
variable that are related to increased medication adherence in general and in the context 
of African Americans with hypertension. For practitioners, it would be interesting to 
determine whether family support pushes hypertensive African Americans to seek 
medication and stay committed to it, or if peer support is more important. Another 
important angle to work on is the quality of relationship between patient and provider—
that is, whether the level of trust between the two parties could have a significant result 
on the medication adherence of patients. This could provide a more nuanced 
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understanding of medication programs and their impact on the patients’ perceptions and 
adherence to medication.  
Another important area to investigate is the perception of patients on the level of 
social support and quality of relationship that they have with their provider. 
Misperceptions and a lack of understanding of the causes and treatment greatly influence 
medication adherence as well (Buis et al., 2014). Thus, it is imperative for African 
Americans diagnosed with hypertension to adhere to treatment to help lower the burden 
of heart disease morbidity and mortality and improve their blood pressure control. It is 
also important for healthcare providers to understand the culture of African Americans, 
and tailor treatment based on the particular needs of the patient (Brown, 2015). Their 
perceptions of these could essentially influence their willingness to adhere to their 
medication. Future researchers could investigate this topic by utilizing a qualitative study. 
Such type emphasizes how patients perceive their experiences, and these experiences 
could affect self-regulatory processes of the patients. Likewise, it would be beneficial for 
future researchers to explore the perception of providers on the different factors that 
affect their patients’ medication adherence. This could provide comprehensive data on 
the relationship among social support, patient-provider communication, and medication 
adherence. 
To summarize, two important recommendations were discussed: (a) it is 
important to further analyze the different aspects of each variable and their association 
with medication adherence, and (b) it is critical for future researchers to exhaust every 
method possible to understand the perceptions of both patients and providers in the 
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context of hypertension and chronic diseases among ethnic minorities. These 
investigations would not only provide additional data but could also improve future 
researchers’ nuanced understanding of the different factors that affect the medication 
adherence of African Americans. In the next section, I will discuss the implications of the 
results for professional practice and social change. 
Implications for Professional Practice and Social Change 
The present study revealed the explicit relationships among social support, 
patient-provider communication, and medication adherence in the context of African 
Americans with hypertension in the United States. Specifically, the results showed that 
patient-provider communication is a significant predictor of medication adherence among 
hypertensive African Americans. This is important especially for researchers to 
understand the dynamics of patients and providers and the former’s commitment to 
improve their health. The results provide additional context regarding factors that 
influence medication adherence and overall healthcare experiences of African Americans 
with hypertension. This also entails practical and social implications, which could 
possibly contribute to the development of medication programs considering the 
effectiveness of patient-provider communication in ensuring the patients’ medication 
adherence. 
Implications for Professional Practice 
Providers are essentially tasked to ensure that the patients trust them enough so 
that the latter would adhere to medication. Trust in a provider is synonymous with 
adherence to treatment. Patient-provider communication is one way to establish trust and 
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encourage individuals to become more involved in decisions regarding their health 
(Martin et al., 2011). The results of the study have shown that providers are extremely 
influential on the patients’ commitment to medication. As such, it is important for 
providers to hone their communication skills in order to build more effective, trust-based 
relationships with patients. Central to this relationship is the role of experience. Future 
researchers can use the knowledge from this study to develop models that explain 
underlying psychological and social processes in the context of medication adherence 
among African Americans with hypertension. The findings of the present study 
contributed to the theoretical knowledge on the relationships among social support, 
patient-provider communication, and medication adherence. The findings may help 
substantiate and develop a model that could encompass the different factors that affect 
medication adherence of hypertensive patients. 
 Educational and organizational leaders may apply the insights from this study to 
create and maintain programs that develop the communication skills of providers through 
providing opportunities for intensive on-the-job experiences and training. This is critical 
in ensuring that counselor-in-training will have the chance to apply their knowledge into 
practice, while at the same time, increasing their self-efficacy in performing job 
responsibilities. Educational and organizational leaders are responsible in developing 
policies that highlight the accessibility of medication especially for ethnic minorities such 
as African Americans.  
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Implications for Social Change 
The findings in this study may contribute to positive social change, especially 
considering the importance of developing providers’ skills in communication to provide 
additional support for hypertensive patients. Previous researchers have suggested that 
African Americans are less likely to seek or receive needed health services, procedures, 
or routine treatments for hypertension in comparison to White Americans (Martin et al., 
2011). This conclusion was also reflected in the results of this study, in which social 
support was not considered a factor in medication adherence of African Americans with 
hypertension. Additionally, patients who engage in decision-making with their healthcare 
provider are not only more likely to be satisfied with the quality of care but are also likely 
to adhere to recommended treatment (Aseltine et al., 2016; Schoenthaler et al., 2009). I 
found that the relationship between patient and provider is foundational to ensure 
medication adherence among hypertensive African Americans. 
This knowledge can be a foundation for policy changes that highlight the role of 
provider to provide opportunities for patients to fully understand and appreciate the 
importance of medication in improving one’s quality of life. This entails not only 
providing more opportunities for firsthand experiential exercises or practicum 
experiences, but also ensuring that the skills development programs deliver quality results 
for the providers. Additionally, in terms of policies, these results support the need to 
reexamine current policies and government programs that focus on the accessibility of 
medication for ethnic minorities with chronic diseases. Given the significant role of the 
provider, policymakers must revisit current laws and policies on health and well-being to 
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ensure that these address the contemporary challenges of racial minority groups with 
chronic illnesses. Lastly, the findings of this study demonstrate that improvements in 
patient-provider communication and social support can help create social change in 
African Americans’ attitudes towards self-management of their health behaviors and 
reduce patient isolation in dealing with chronic illnesses including hypertension.  
Conclusion 
A lack of effective health provider response to uncontrolled blood pressure and 
insufficient patient adherence to treatment recommendations create a problem for 
hypertensive individuals to maintain their blood pressure. Thus, the purpose of this 
quantitative study was to examine the association of social support and patient-provider 
communication towards medication adherence for both hypertensive African American 
men and women between the ages of 21–65 years in the United States. The results of the 
analyses showed that among the three research questions, only Research Question 1 
indicated significant results. I found that patient-provider communication is a positive 
and significant predictor of medication adherence of African Americans with 
hypertension.  
Social support, however, was not found to significantly predict medication 
adherence. There was also no significant difference on medication adherence by age and 
gender. It is critical for researchers to understand the dynamics of patients and providers 
and the former’s commitment to improve their health. The results of this study provide 
additional context regarding factors that influence medication adherence and overall 
healthcare experiences of African Americans with hypertension. Thus, I recommend that 
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future scholars focus on a nuanced understanding on the different factors that affect the 
medication adherence of African Americans. Policies and skills development programs 
must be further enhanced in order to support the critical role of providers in ensuring 
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